1
|
Ashworth ET, Burrowes KS, Clark AR, Ebrahimi BSS, Tawhai MH. An in silico approach to understanding the interaction between cardiovascular and pulmonary lymphatic dysfunction. Am J Physiol Heart Circ Physiol 2023; 324:H318-H329. [PMID: 36607796 DOI: 10.1152/ajpheart.00591.2022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
The lung is extremely sensitive to interstitial fluid balance, yet the role of pulmonary lymphatics in lung fluid homeostasis and its interaction with cardiovascular pressures is poorly understood. In health, there is a fine balance between fluid extravasated from the pulmonary capillaries into the interstitium and the return of fluid to the circulation via the lymphatic vessels. This balance is maintained by an extremely interdependent system governed by pressures in the fluids (air and blood) and tissue (interstitium), lung motion during breathing, and the permeability of the tissues. Chronic elevation in left atrial pressure (LAP) due to left heart disease increases the capillary blood pressure. The consequent fluid accumulation in the delicate lung tissue increases its weight, decreases its compliance, and impairs gas exchange. This interdependent system is difficult, if not impossible, to study experimentally. Computational modeling provides a unique perspective to analyze fluid movement in the cardiopulmonary vasculature in health and disease. We have developed an initial in silico model of pulmonary lymphatic function using an anatomically structured model to represent ventilation and perfusion and underlying biophysical laws governing fluid transfer at the interstitium. This novel model was tested against increased LAP and noncardiogenic effects (increased permeability). The model returned physiologically reasonable values for all applications, predicting pulmonary edema when LAP reached 25 mmHg and with increased permeability.NEW & NOTEWORTHY This model presents a novel approach to understanding the interaction between cardiac dysfunction and pulmonary lymphatic function, using anatomically structured models and biophysical equations to estimate regional variation in fluid transport from blood to interstitial and lymphatic flux. This fluid transport model brings together advanced models of ventilation, perfusion, and lung mechanics to produce a detailed model of fluid transport in health and various altered pathological conditions.
Collapse
Affiliation(s)
- E T Ashworth
- Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand
| | - K S Burrowes
- Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand
| | - A R Clark
- Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand
| | | | - M H Tawhai
- Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand
| |
Collapse
|
2
|
James JL, Tongpob Y, Srinivasan V, Crew RC, Bappoo N, Doyle B, Gerneke D, Clark AR, Wyrwoll CS. Three-dimensional visualisation of the feto-placental vasculature in humans and rodents. Placenta 2021; 114:8-13. [PMID: 34418753 DOI: 10.1016/j.placenta.2021.08.049] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/05/2021] [Revised: 08/09/2021] [Accepted: 08/12/2021] [Indexed: 11/19/2022]
Abstract
Adequate development of the feto-placental circulation is critical for placental exchange function and healthy fetal growth. Understanding the structure of this circulation and how it informs fetal outcomes is important both in the human placenta, and the rodent, a purported comparative experimental model. Vascular casting and micro-CT imaging approaches enable detailed quantification of the complex vascular relationships in the feto-circulation, and provide detailed data to parameterise in silico models. Here, to assist researchers to apply these technically challenging methods we provide detailed approaches to cast and image; 1) human placentas at the cotyledon-level, and 2) whole rodent placentas.
Collapse
Affiliation(s)
- J L James
- Department of Obstetrics and Gynaecology, Faculty of Medical and Health Sciences, University of Auckland, New Zealand
| | - Y Tongpob
- School of Human Sciences, The University of Western Australia, Perth, WA, Australia; Faculty of Medical Science, Naresuan University, Phitsanulok, Thailand
| | - V Srinivasan
- Auckland Bioengineering Institute, University of Auckland, New Zealand
| | - R C Crew
- School of Human Sciences, The University of Western Australia, Perth, WA, Australia
| | - N Bappoo
- School of Human Sciences, The University of Western Australia, Perth, WA, Australia; Vascular Engineering Laboratory, Harry Perkins Institute of Medical Research, QEII Medical Centre and the UWA Centre for Medical Research, The University of Western Australia, WA, Australia; School of Engineering, The University of Western Australia, Perth, WA, 6009, Australia
| | - B Doyle
- Vascular Engineering Laboratory, Harry Perkins Institute of Medical Research, QEII Medical Centre and the UWA Centre for Medical Research, The University of Western Australia, WA, Australia; School of Engineering, The University of Western Australia, Perth, WA, 6009, Australia; Australian Research Council Centre for Personalised Therapeutics Technologies, Australia; Centre for Cardiovascular Science, The University of Edinburgh, UK
| | - D Gerneke
- Auckland Bioengineering Institute, University of Auckland, New Zealand
| | - A R Clark
- Auckland Bioengineering Institute, University of Auckland, New Zealand
| | - C S Wyrwoll
- School of Human Sciences, The University of Western Australia, Perth, WA, Australia.
| |
Collapse
|
3
|
Tawhai MH, Clark AR, Chase JG. The Lung Physiome and virtual patient models: From morphometry to clinical translation. Morphologie 2019; 103:131-138. [PMID: 31570307 DOI: 10.1016/j.morpho.2019.09.003] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2019] [Accepted: 09/10/2019] [Indexed: 06/10/2023]
Abstract
The understanding or prediction of specific functions of the lung can be made using compact models that have identifiable parameters and that are custom designed to the problem of interest. However, when structure contributes to function - as is the case with most lung pathologies - structure-based, biophysical models become essential. Here we describe the application of structure-based models within the lung Physiome framework to identifying and explaining patient risk in 12patients diagnosed with acute pulmonary embolism. The model integrates perfusion, ventilation, and gas exchange to predict arterial blood gases and pulmonary artery pressure in individual patient models in response to patient-specific blood clot distribution, with full or partial arterial occlusion. The necessity for a patient-specific approach with biophysical models that account for scale-specific structure and function is demonstrated.
Collapse
Affiliation(s)
- M H Tawhai
- Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand.
| | - A R Clark
- Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand
| | - J G Chase
- Department of Mechanical Engineering, University of Canterbury, Christchurch, New Zealand
| |
Collapse
|
4
|
Paller A, Jaworski JC, Simpson EL, Boguniewicz M, Russell JJ, Block JK, Tofte S, Dunn JD, Feldman SR, Clark AR, Schwartz G, Eichenfield LF. Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders. Am J Clin Dermatol 2018; 19:821-838. [PMID: 30168085 DOI: 10.1007/s40257-018-0383-4] [Citation(s) in RCA: 133] [Impact Index Per Article: 22.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
The consequences of atopic dermatitis reach beyond the skin and past childhood. Patients with atopic dermatitis are at risk of developing allergic comorbidities, but less is known about the associations between atopic dermatitis and non-allergic conditions. Understanding these non-allergic comorbidities has the potential to improve patient outcomes and to help mitigate the cost and burdens associated with these conditions. Atopic dermatitis is associated with cutaneous bacterial infections, more severe forms/courses of cutaneous viral infections, and extra-cutaneous infections. Atopic dermatitis is also associated with several mental health comorbidities particularly attention-deficit hyperactivity disorder, anxiety, and depression. Data are largely inconsistent for specific cancers, but atopic dermatitis appears to protect against malignancy overall; severe long-term atopic dermatitis is associated with adult lymphomas. Atopic dermatitis may also be associated with obesity, cardiovascular disease, and autoimmune disease, particularly alopecia areata and gastrointestinal immune-mediated disorders. Although the causative mechanisms underlying these associations are poorly understood, treating physicians should be aware of associations in seeking to alleviate the burden for patients with atopic dermatitis.
Collapse
|
5
|
Abstract
Altered parenchymal microstructure and complexity have been observed in older age. How to distinguish between healthy, expected changes and early signs of pathology remains poorly understood. An objective quantitative analysis of computed tomography imaging was conducted to compare mean lung density, tissue density distributions, and tissue heterogeneity in 16 subjects, 8 aged >60 yr who were gender and body mass index matched with 8 subjects aged <30 yr. Subjects had never been smokers, with no prior respiratory disease, and no radiologically identified abnormalities on computed tomography. Volume-controlled breath hold imaging acquired at 80% vital capacity (end inspiration) and 55% vital capacity (end expiration) were used for analysis. Mean lung density was not different between the age groups at end inspiration ( P = 0.806) but was larger in the younger group at end expiration (0.26 ± 0.033 vs. 0.22 ± 0.026, P = 0.008), as is expected due to increased air trapping in the older population. However, gravitational gradients of tissue density did not differ with age; the only difference in distribution of tissue density between the two age groups was a lower density in the apices of the older group at end expiration. The heterogeneity of the lung tissue assessed using two metrics showed significant differences between end inspiration and end expiration, no dependence on age, and a significant relationship with body mass index at both lung volumes when heterogeneity was calculated using quadtree decomposition but only at end expiration when using a fractal dimension. NEW & NOTEWORTHY Changes to lung tissue heterogeneity can be a normal part of aging but can also be an early indicator of disease. We use novel techniques, which have previously not been used on thoracic computed tomography imaging, to quantify lung tissue heterogeneity in young and old healthy subjects. Our results show no dependence on age but a significant correlation with body mass index.
Collapse
Affiliation(s)
- K Subramaniam
- Auckland Bioengineering Institute, University of Auckland , Auckland , New Zealand
| | - A R Clark
- Auckland Bioengineering Institute, University of Auckland , Auckland , New Zealand
| | - E A Hoffman
- Departments of Radiology and Bioengineering, University of Iowa , Iowa City, Iowa
| | - M H Tawhai
- Auckland Bioengineering Institute, University of Auckland , Auckland , New Zealand
| |
Collapse
|
6
|
O'Neil JD, Ammit AJ, Clark AR. MAPK p38 regulates inflammatory gene expression via tristetraprolin: Doing good by stealth. Int J Biochem Cell Biol 2018; 94:6-9. [PMID: 29128684 PMCID: PMC6562201 DOI: 10.1016/j.biocel.2017.11.003] [Citation(s) in RCA: 40] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2017] [Accepted: 11/07/2017] [Indexed: 12/14/2022]
Abstract
Tristetraprolin (TTP) is an RNA-destabilizing protein that exerts profound anti-inflammatory effects by inhibiting the expression of tumour necrosis factor and many other inflammatory mediators. The mitogen-activated protein kinase (MAPK) p38 signaling pathway controls the strength and duration of inflammatory responses by regulating both the expression and function of TTP. The kinase MK2 (MAPK activated kinase 2) is activated by MAPK p38, and in turn phosphorylates TTP at two critical serine residues. One consequence of these phosphorylations is the protection of TTP from proteasome-mediated degradation. Another consequence is the loss of mRNA destabilizing activity. The control of TTP expression and function by the MAPK p38 pathway provides an elegant mechanism for coupling the on and off phases of inflammatory responses, and dictating the precise kinetics of expression of individual inflammatory mediators.
Collapse
Affiliation(s)
- J D O'Neil
- Institute of Inflammation and Ageing, University of Birmingham, Birmingham B15 2WB, United Kingdom
| | - A J Ammit
- Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, New South Wales, Australia; School of Life Sciences, Faculty of Science, University of Technology, Sydney, New South Wales, Australia
| | - A R Clark
- Institute of Inflammation and Ageing, University of Birmingham, Birmingham B15 2WB, United Kingdom.
| |
Collapse
|
7
|
Bulbrook D, Brazier H, Mahajan P, Kliszczak M, Fedorov O, Marchese FP, Aubareda A, Chalk R, Picaud S, Strain-Damerell C, Filippakopoulos P, Gileadi O, Clark AR, Yue WW, Burgess-Brown NA, Dean JLE. Tryptophan-Mediated Interactions between Tristetraprolin and the CNOT9 Subunit Are Required for CCR4-NOT Deadenylase Complex Recruitment. J Mol Biol 2017; 430:722-736. [PMID: 29291391 DOI: 10.1016/j.jmb.2017.12.018] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2017] [Revised: 12/19/2017] [Accepted: 12/20/2017] [Indexed: 12/27/2022]
Abstract
The zinc-finger protein tristetraprolin (TTP) binds to AU-rich elements present in the 3' untranslated regions of transcripts that mainly encode proteins of the inflammatory response. TTP-bound mRNAs are targeted for destruction via recruitment of the eight-subunit deadenylase complex "carbon catabolite repressor protein 4 (CCR4)-negative on TATA-less (NOT)," which catalyzes the removal of mRNA poly-(A) tails, the first obligatory step in mRNA decay. Here we show that a novel interaction between TTP and the CCR4-NOT subunit, CNOT9, is required for recruitment of the deadenylase complex. In addition to CNOT1, CNOT9 is now included in the identified CCR4-NOT subunits shown to interact with TTP. We find that both the N- and C-terminal domains of TTP are involved in an interaction with CNOT9. Through a combination of SPOT peptide array, site-directed mutagenesis, and bio-layer interferometry, we identified several conserved tryptophan residues in TTP that serve as major sites of interaction with two tryptophan-binding pockets of CNOT9, previously found to interact with another modulator GW182. We further demonstrate that these interactions are also required for recruitment of the CCR4-NOT complex and TTP-directed decay of an mRNA containing an AU-rich element in its 3'-untranslated region. Together the results reveal new molecular details for the TTP-CNOT interaction that shape an emerging mechanism whereby TTP targets inflammatory mRNAs for deadenylation and decay.
Collapse
Affiliation(s)
- D Bulbrook
- Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Roosevelt Drive, Headington, Oxford, OX3 7FY, United Kingdom
| | - H Brazier
- Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Roosevelt Drive, Headington, Oxford, OX3 7FY, United Kingdom; Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford, OX3 7DQ, United Kingdom
| | - P Mahajan
- Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford, OX3 7DQ, United Kingdom
| | - M Kliszczak
- Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford, OX3 7DQ, United Kingdom
| | - O Fedorov
- Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford, OX3 7DQ, United Kingdom
| | - F P Marchese
- Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Roosevelt Drive, Headington, Oxford, OX3 7FY, United Kingdom
| | - A Aubareda
- Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Roosevelt Drive, Headington, Oxford, OX3 7FY, United Kingdom
| | - R Chalk
- Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford, OX3 7DQ, United Kingdom
| | - S Picaud
- Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford, OX3 7DQ, United Kingdom
| | - C Strain-Damerell
- Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford, OX3 7DQ, United Kingdom
| | - P Filippakopoulos
- Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford, OX3 7DQ, United Kingdom; Ludwig Institute for Cancer Research, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, United Kingdom
| | - O Gileadi
- Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford, OX3 7DQ, United Kingdom
| | - A R Clark
- Institute of Inflammation and Ageing, University of Birmingham, Edgbaston, B15 2TT, United Kingdom
| | - W W Yue
- Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford, OX3 7DQ, United Kingdom.
| | - N A Burgess-Brown
- Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford, OX3 7DQ, United Kingdom.
| | - J L E Dean
- Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Roosevelt Drive, Headington, Oxford, OX3 7FY, United Kingdom.
| |
Collapse
|
8
|
Kang W, Clark AR, Tawhai MH. Gravity outweighs the contribution of structure to passive ventilation-perfusion matching in the supine adult human lung. J Appl Physiol (1985) 2017; 124:23-33. [PMID: 29051337 DOI: 10.1152/japplphysiol.00791.2016] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Gravity and matched airway/vascular tree geometries are both hypothesized to be key contributors to ventilation-perfusion (V̇/Q̇) matching in the lung, but their relative contributions are challenging to quantify experimentally. We used a structure-based model to conduct an analysis of the relative contributions of tissue deformation (the "Slinky" effect), other gravitational mechanisms (weight of blood and gravitational gradient in tissue elastic recoil), and matched airway and arterial tree geometry to V̇/Q̇ matching and therefore to total lung oxygen exchange. Our results showed that the heterogeneity in V̇ and Q̇ were lowest and the correlation between V̇ and Q̇ was highest when the only mechanism for V̇/Q̇ matching was either tissue deformation or matched geometry. Heterogeneity in V̇ and Q̇ was highest and their correlation was poorest when all mechanisms were active (that is, at baseline). Eliminating the contribution of matched geometry did not change the correlation between V̇ and Q̇ at baseline. Despite the much larger heterogeneities in V̇ and Q̇ at baseline, the contribution of in-common (to V̇ and Q̇) gravitational mechanisms provided sufficient compensatory V̇/Q̇ matching to minimize the impact on oxygen transfer. In summary, this model predicts that during supine normal breathing under gravitational loading, passive V̇/Q̇ matching is predominantly determined by shared gravitationally induced tissue deformation, compliance distribution, and the effect of the hydrostatic pressure gradient on vessel and capillary size and blood pressures. Contribution from the matching airway and arterial tree geometries in this model is minor under normal gravity in the supine adult human lung. NEW & NOTEWORTHY We use a computational model to systematically analyze contributors to ventilation-perfusion matching in the lung. The model predicts that the multiple effects of gravity are the predominant mechanism in providing passive ventilation-perfusion matching in the supine adult human lung under normal gravitational loads, while geometric matching of airway and arterial trees plays a minor role.
Collapse
Affiliation(s)
- W Kang
- Auckland Bioengineering Institute, University of Auckland , Auckland , New Zealand
| | - A R Clark
- Auckland Bioengineering Institute, University of Auckland , Auckland , New Zealand
| | - M H Tawhai
- Auckland Bioengineering Institute, University of Auckland , Auckland , New Zealand
| |
Collapse
|
9
|
Clark AR, Pendleton N, Leroi I. 161Depression Scores In Healthy Older Adults Link To Speed Of Processing But Not To Change In Processing Speed Over Time. Age Ageing 2017. [DOI: 10.1093/ageing/afx066.161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
10
|
Fletcher NF, Clark AR, Balfe P, McKeating JA. TNF superfamily members promote hepatitis C virus entry via an NF-κB and myosin light chain kinase dependent pathway. J Gen Virol 2017; 98:405-412. [PMID: 27983476 PMCID: PMC5797950 DOI: 10.1099/jgv.0.000689] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
Preventing virally induced liver disease begins with an understanding of the host factors that define susceptibility to infection. Hepatitis C virus (HCV) is a global health issue, with an estimated 170 million infected individuals at risk of developing liver disease including fibrosis and hepatocellular carcinoma. The liver is the major reservoir supporting HCV replication and this hepatocellular tropism is defined by HCV engagement of cellular entry receptors. Hepatocytes are polarized in vivo and this barrier function limits HCV entry. We previously reported that activated macrophages promote HCV entry into polarized hepatocytes via a TNF-α-dependent process; however, the underlying mechanism was not defined. In this study, we show that several TNF superfamily members, including TNF-α, TNF-β, TWEAK and LIGHT, promote HCV entry via NF-κB-mediated activation of myosin light chain kinase (MLCK) and disruption of tight junctions. These observations support a model where HCV hijacks an inflammatory immune response to stimulate infection and uncovers a role for NF-κB-MLCK signalling in maintaining hepatocellular tight junctions.
Collapse
Affiliation(s)
- N F Fletcher
- Centre for Human Virology, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
| | - A R Clark
- Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
| | - P Balfe
- Centre for Human Virology, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
| | - J A McKeating
- Present address: Nuffield Department of Medicine, University of Oxford, UK.,Centre for Human Virology, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
| |
Collapse
|
11
|
Ross EA, Naylor AJ, O'Neil JD, Crowley T, Ridley ML, Crowe J, Smallie T, Tang TJ, Turner JD, Norling LV, Dominguez S, Perlman H, Verrills NM, Kollias G, Vitek MP, Filer A, Buckley CD, Dean JL, Clark AR. Treatment of inflammatory arthritis via targeting of tristetraprolin, a master regulator of pro-inflammatory gene expression. Ann Rheum Dis 2016; 76:612-619. [PMID: 27597652 PMCID: PMC5446007 DOI: 10.1136/annrheumdis-2016-209424] [Citation(s) in RCA: 51] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2016] [Revised: 08/10/2016] [Accepted: 08/11/2016] [Indexed: 02/07/2023]
Abstract
OBJECTIVES Tristetraprolin (TTP), a negative regulator of many pro-inflammatory genes, is strongly expressed in rheumatoid synovial cells. The mitogen-activated protein kinase (MAPK) p38 pathway mediates the inactivation of TTP via phosphorylation of two serine residues. We wished to test the hypothesis that these phosphorylations contribute to the development of inflammatory arthritis, and that, conversely, joint inflammation may be inhibited by promoting the dephosphorylation and activation of TTP. METHODS The expression of TTP and its relationship with MAPK p38 activity were examined in non-inflamed and rheumatoid arthritis (RA) synovial tissue. Experimental arthritis was induced in a genetically modified mouse strain, in which endogenous TTP cannot be phosphorylated and inactivated. In vitro and in vivo experiments were performed to test anti-inflammatory effects of compounds that activate the protein phosphatase 2A (PP2A) and promote dephosphorylation of TTP. RESULTS TTP expression was significantly higher in RA than non-inflamed synovium, detected in macrophages, vascular endothelial cells and some fibroblasts and co-localised with MAPK p38 activation. Substitution of TTP phosphorylation sites conferred dramatic protection against inflammatory arthritis in mice. Two distinct PP2A agonists also reduced inflammation and prevented bone erosion. In vitro anti-inflammatory effects of PP2A agonism were mediated by TTP activation. CONCLUSIONS The phosphorylation state of TTP is a critical determinant of inflammatory responses, and a tractable target for novel anti-inflammatory treatments.
Collapse
Affiliation(s)
- E A Ross
- Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK
| | - A J Naylor
- Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
| | - J D O'Neil
- Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
| | - T Crowley
- Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
| | - M L Ridley
- Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
| | - J Crowe
- Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK
| | - T Smallie
- Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
| | - T J Tang
- Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
| | - J D Turner
- Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
| | - L V Norling
- William Harvey Research Institute, QMUL, London, UK
| | - S Dominguez
- Division of Rheumatology, Northwestern University, Chicago, Illinois, USA
| | - H Perlman
- Division of Rheumatology, Northwestern University, Chicago, Illinois, USA
| | - N M Verrills
- School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales, Australia
| | - G Kollias
- Division of Immunology, Biomedical Sciences Research Center 'Alexander Fleming', Vari, Greece
| | - M P Vitek
- Cognosci Inc., Research Triangle Park, North Carolina, USA
| | - A Filer
- Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
| | - C D Buckley
- Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
| | - J L Dean
- Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK
| | - A R Clark
- Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK
| |
Collapse
|
12
|
Eichenfield LF, Boguniewicz M, Simpson EL, Russell JJ, Block JK, Feldman SR, Clark AR, Tofte S, Dunn JD, Paller AS. Translating Atopic Dermatitis Management Guidelines Into Practice for Primary Care Providers. Pediatrics 2015; 136:554-65. [PMID: 26240216 DOI: 10.1542/peds.2014-3678] [Citation(s) in RCA: 62] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 02/26/2015] [Indexed: 11/24/2022] Open
Abstract
Atopic dermatitis affects a substantial number of children, many of whom seek initial treatment from their pediatrician or other primary care provider. Approximately two-thirds of these patients have mild disease and can be adequately managed at the primary care level. However, recent treatment guidelines are written primarily for use by specialists and lack certain elements that would make them more useful to primary care providers. This article evaluates these recent treatment guidelines in terms of evaluation criteria, treatment recommendations, usability, accessibility, and applicability to nonspecialists and integrates them with clinical evidence to present a streamlined severity-based treatment model for the management of a majority of atopic dermatitis cases. Because each patient's situation is unique, individualization of treatment plans is critical as is efficient communication and implementation of the plan with patients and caregivers. Specifically, practical suggestions for individualizing, optimizing, implementing, and communicating treatment plans such as choosing a moisturizer formulation, avoiding common triggers, educating patients/caregivers, providing written treatment plans, and scheduling physician follow-up are provided along with a discussion of available resources for patients/caregivers and providers.
Collapse
Affiliation(s)
- Lawrence F Eichenfield
- Departments of Pediatrics and Dermatology, School of Medicine, University of California, San Diego, San Diego, California;
| | - Mark Boguniewicz
- Division of Pediatric Allergy-Immunology, Department of Pediatrics, National Jewish Health and School of Medicine, University of Colorado Denver, Colorado
| | | | - John J Russell
- Department of Family and Community Medicine, Sydney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania
| | | | - Steven R Feldman
- Department of Dermatology, Pathology, and Public Health Sciences, Wake Forest Baptist Health, Winston-Salem, North Carolina
| | | | - Susan Tofte
- Nursing, Oregon Health & Science University, Portland, Oregon
| | | | - Amy S Paller
- Departments of Dermatology and Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
| |
Collapse
|
13
|
Abstract
The placenta provides all the nutrients required for the fetus through pregnancy. It develops dynamically, and, to avoid rejection of the fetus, there is no mixing of fetal and maternal blood; rather, the branched placental villi 'bathe' in blood supplied from the uterine arteries. Within the villi, the feto-placental vasculature also develops a complex branching structure in order to maximize exchange between the placental and maternal circulations. To understand the development of the placenta, we must translate functional information across spatial scales including the interaction between macro- and micro-scale haemodynamics and account for the effects of a dynamically and rapidly changing structure through the time course of pregnancy. Here, we present steps towards an anatomically based and multiscale approach to modelling the feto-placental circulation. We assess the effect of the location of cord insertion on feto-placental blood flow resistance and flow heterogeneity and show that, although cord insertion does not appear to directly influence feto-placental resistance, the heterogeneity of flow in the placenta is predicted to increase from a 19.4% coefficient of variation with central cord insertion to 23.3% when the cord is inserted 2 cm from the edge of the placenta. Model geometries with spheroidal and ellipsoidal shapes, but the same volume, showed no significant differences in flow resistance or heterogeneity, implying that normal asymmetry in shape does not affect placental efficiency. However, the size and number of small capillary vessels is predicted to have a large effect on feto-placental resistance and flow heterogeneity. Using this new model as an example, we highlight the importance of taking an integrated multi-disciplinary and multiscale approach to understand development of the placenta.
Collapse
Affiliation(s)
- A R Clark
- Auckland Bioengineering Institute , University of Auckland , Auckland , New Zealand
| | - M Lin
- Auckland Bioengineering Institute , University of Auckland , Auckland , New Zealand
| | - M Tawhai
- Auckland Bioengineering Institute , University of Auckland , Auckland , New Zealand
| | - R Saghian
- Auckland Bioengineering Institute , University of Auckland , Auckland , New Zealand
| | - J L James
- Obstetrics and Gynaecology , University of Auckland , Auckland , New Zealand
| |
Collapse
|
14
|
Hoover WD, Jorizzo JL, Clark AR, Feldman SR, Holbrook J, Huang KE. Efficacy of cryosurgery and 5-fluorouracil cream 0.5% combination therapy for the treatment of actinic keratosis. Cutis 2014; 94:255-259. [PMID: 25474455] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
Actinic keratoses (AKs) are on a continuum of progression to squamous cell carcinoma (SCC). The most common AK treatment modalities are lesion-directed cryosurgery and field-directed therapy with 5-fluorouracil (5-FU); however, side effects can affect patient compliance. This study was performed to determine the efficacy and perceived side effects of combination treatment with cryosurgery and a shortened course of 5-FU cream 0.5% for AK lesions. Sixty participants with AK lesions underwent cryosurgery and were then randomized to apply 5-FU cream 0.5% or comparator cream once daily to the study area for 1 week. Participants were evaluated at weeks 3, 4, 8, and 26. After 8 weeks, treatment with cryosurgery and 5-FU cream 0.5% was more likely to result in complete clearance versus cryosurgery alone; however, no statistical difference was found in the complete clearance of AK lesions in the treatment group compared to cryosurgery alone at 26 weeks, while side effects in the treatment group were decreased. This study demonstrated the benefit of combination treatment of cryosurgery with 1 week of 5-FU compared to cryosurgery alone in clearing AK lesions for 2 months. This study shows promise for future studies with larger sample sizes to illustrate increased efficacy and decreased side effects with combination treatment of AKs with cryosurgery and 5-FU.
Collapse
Affiliation(s)
| | | | - Adele R Clark
- Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157, USA.
| | | | | | | |
Collapse
|
15
|
Burrowes KS, Clark AR, Wilsher ML, Milne DG, Tawhai MH. Hypoxic pulmonary vasoconstriction as a contributor to response in acute pulmonary embolism. Ann Biomed Eng 2014; 42:1631-43. [PMID: 24770844 DOI: 10.1007/s10439-014-1011-y] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2013] [Accepted: 04/11/2014] [Indexed: 01/12/2023]
Abstract
Hypoxic pulmonary vasoconstriction (HPV) is an adaptive response unique to the lung whereby blood flow is diverted away from areas of low alveolar oxygen to improve ventilation-perfusion matching and resultant gas exchange. Some previous experimental studies have suggested that the HPV response to hypoxia is blunted in acute pulmonary embolism (APE), while others have concluded that HPV contributes to elevated pulmonary blood pressures in APE. To understand these contradictory observations, we have used a structure-based computational model of integrated lung function in 10 subjects to study the impact of HPV on pulmonary hemodynamics and gas exchange in the presence of regional arterial occlusion. The integrated model includes an experimentally-derived model for HPV. Its function is validated against measurements of pulmonary vascular resistance in normal subjects at four levels of inspired oxygen. Our results show that the apparently disparate observations of previous studies can be explained within a single model: the model predicts that HPV increases mean pulmonary artery pressure in APE (by 8.2 ± 7.0% in these subjects), and concurrently shows a reduction in response to hypoxia in the subjects who have high levels of occlusion and therefore maximal HPV in normoxia.
Collapse
Affiliation(s)
- K S Burrowes
- Department of Computer Science, University of Oxford, Wolfson Building, Parks Road, Oxford, OX1 3QD, UK,
| | | | | | | | | |
Collapse
|
16
|
Abstract
Acute pulmonary embolism causes redistribution of blood in the lung, which impairs ventilation/perfusion matching and gas exchange and can elevate pulmonary arterial pressure (PAP) by increasing pulmonary vascular resistance (PVR). An anatomically-based multi-scale model of the human pulmonary circulation was used to simulate pre- and post-occlusion flow, to study blood flow redistribution in the presence of an embolus, and to evaluate whether reduction in perfused vascular bed is sufficient to increase PAP to hypertensive levels, or whether other vasoconstrictive mechanisms are necessary. A model of oxygen transfer from air to blood was included to assess the impact of vascular occlusion on oxygen exchange. Emboli of 5, 7, and 10 mm radius were introduced to occlude increasing proportions of the vasculature. Blood flow redistribution was calculated after arterial occlusion, giving predictions of PAP, PVR, flow redistribution, and micro-circulatory flow dynamics. Because of the large flow reserve capacity (via both capillary recruitment and distension), approximately 55% of the vasculature was occluded before PAP reached clinically significant levels indicative of hypertension. In contrast, model predictions showed that even relatively low levels of occlusion could cause localized oxygen deficit. Flow preferentially redistributed to gravitationally non-dependent regions regardless of occlusion location, due to the greater potential for capillary recruitment in this region. Red blood cell transit times decreased below the minimum time for oxygen saturation (<0.25 s) and capillary pressures became high enough to initiate cell damage (which may result in edema) only after ~80% of the lung was occluded.
Collapse
Affiliation(s)
- K S Burrowes
- Department of Computer Science, University of Oxford, United Kingdom
| | | | | |
Collapse
|
17
|
Yentzer BA, Wood AA, Sagransky MJ, O'Neill JL, Clark AR, Williams LL, Feldman SR. An Internet-based survey and improvement of acne treatment outcomes. ACTA ACUST UNITED AC 2011; 147:1223-4. [PMID: 22006146 DOI: 10.1001/archdermatol.2011.277] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
18
|
Burrowes KS, Clark AR, Marcinkowski A, Wilsher ML, Milne DG, Tawhai MH. Pulmonary embolism: predicting disease severity. Philos Trans A Math Phys Eng Sci 2011; 369:4255-4277. [PMID: 21969675 DOI: 10.1098/rsta.2011.0129] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Pulmonary embolism (PE) is the most common cause of acute pulmonary hypertension, yet it is commonly undiagnosed, with risk of death if not recognized promptly and managed accordingly. Patients typically present with hypoxemia and hypomania, although the presentation varies greatly, being confounded by co-morbidities such as pre-existing cardio-respiratory disease. Previous studies have demonstrated variable patient outcomes in spite of similar extent and distribution of pulmonary vascular occlusion, but the path physiological determinants of outcome remain unclear. Computational models enable exact control over many of the compounding factors leading to functional outcomes and therefore provide a useful tool to understand and assess these mechanisms. We review the current state of pulmonary blood flow models. We present a pilot study within 10 patients presenting with acute PE, where patient-derived vascular occlusions are imposed onto an existing model of the pulmonary circulation enabling predictions of resultant haemodynamic after embolus occlusion. Results show that mechanical obstruction alone is not sufficient to cause pulmonary arterial hypertension, even when up to 65 per cent of lung tissue is occluded. Blood flow is found to preferentially redistribute to the gravitationally non-dependent regions. The presence of an additional downstream occlusion is found to significantly increase pressures.
Collapse
Affiliation(s)
- K S Burrowes
- Department of Computer Science, University of Oxford, Wolfson Building, Parks Road, Oxford, OX1 3QD, UK.
| | | | | | | | | | | |
Collapse
|
19
|
Clark AR, Stokes YM, Thompson JG. Estimation of glucose uptake by ovarian follicular cells. Ann Biomed Eng 2011; 39:2654-67. [PMID: 21769539 DOI: 10.1007/s10439-011-0353-y] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2011] [Accepted: 07/06/2011] [Indexed: 10/18/2022]
Abstract
In vitro maturation (IVM) of mammalian oocytes provides an alternative to traditional in vitro fertilization techniques for clinical treatment of infertility or animal breeding. IVM involves the collection of oocytes from the ovary prior to ovulation, with maturation occurring in a laboratory environment. The success of IVM is highly sensitive to the in vitro nutrient environment. The nurse cells surrounding the oocyte, known as cumulus cells, regulate this environment and removal of these cells reduces the ability of the oocyte to develop following insemination. Determining the nature of the interaction between the oocyte and cumulus cells, collectively called the cumulus-oocyte complex (COC), is a difficult task experimentally. Here we use a combination of experimental and mathematical techniques to investigate glucose transport within bovine COCs and find quantitative estimates of the glucose uptake rates of the oocyte and cumulus cells. Surprisingly, our modeling shows the rate of uptake of glucose by the oocyte to increase and then decrease with concentration, a result that needs further experimental investigation but which supports the expectation that high and low glucose concentrations are detrimental to oocyte development. The methodology described is suitable for use across species and for investigating the transport of other important nutrients within the COC.
Collapse
Affiliation(s)
- A R Clark
- Auckland Bioengineering Institute, The University of Auckland, Auckland, New Zealand.
| | | | | |
Collapse
|
20
|
Miller DW, Koch SB, Yentzer BA, Clark AR, O'Neill JR, Fountain J, Weber TM, Fleischer AB. An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial. J Drugs Dermatol 2011; 10:531-537. [PMID: 21533301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
BACKGROUND Atopic dermatitis (AD) is a prevalent skin disorder with significant cost of treatment. Several prescription device moisturizers have been approved by the FDA to treat AD but are significantly more expensive than well-crafted over-the-counter (OTC) moisturizers. No studies have been performed to compare both the clinical efficacy and cost-efficacy of these prescription devices to OTC moisturizers. PURPOSE The purpose of this study is to compare the clinical efficacy and cost-efficacy of a glycyrrhetinic acid-containing barrier repair cream (BRC-Gly, Atopiclair®), a ceramide-dominant barrier repair cream (BRC-Cer, EpiCeram®) and an OTC petroleum-based skin protectant moisturizer (OTC-Pet, Aquaphor Healing Ointment®) as monotherapy for mild-to-moderate AD in children. METHODS Thirty-nine patients, age 2-17 years, with mild-to-moderate AD were randomized 1:1:1 to receive one of three treatments-BRC-Gly, BRC-Cer or OTC-Pet-with instructions to apply the treatment three times daily for three weeks. Disease severity and improvement was assessed at baseline and on days 7 and 21. RESULTS No statistically significant difference for any efficacy assessment was found between the three groups at each time point. The OTC-Pet was found to be at least 47 times more cost-effective than BRC-Gly or BRC-Cer. LIMITATIONS The relatively small sample size of 39 subjects was not sufficient to establish OTC-Pet as superior treatment in AD. CONCLUSIONS OTC-Pet is as effective in treating mild-to-moderate AD as both BRC-Gly and BRC-Cer and is at least 47 times more cost-effective. NAME OF REGISTRY II-AF-ATD-Aquaphor, Comparing the Efficacy and Cost-Effectiveness of Aquaphor to Atopiclair and EpiCeram in Children with Mild to Moderate Atopic Dermatitis. REGISTRATION IDENTIFIER: NCT01093469.
Collapse
Affiliation(s)
- Drew W Miller
- Department of Dermatology,Wake Forest University School of Medicine,Winston-Salem, NC 27104, USA
| | | | | | | | | | | | | | | |
Collapse
|
21
|
Yentzer BA, Gosnell AL, Clark AR, Pearce DJ, Balkrishnan R, Camacho FT, Young TA, Fountain JM, Fleischer AB, Colón LE, Johnson LA, Preston N, Feldman SR. A randomized controlled pilot study of strategies to increase adherence in teenagers with acne vulgaris. J Am Acad Dermatol 2011; 64:793-5. [DOI: 10.1016/j.jaad.2010.05.008] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2010] [Revised: 04/27/2010] [Accepted: 05/06/2010] [Indexed: 11/24/2022]
|
22
|
Clark AR, Naylor CE, Bagnéris C, Keep NH, Slingsby C. Crystal structure of R120G disease mutant of human αB-crystallin domain dimer shows closure of a groove. J Mol Biol 2011; 408:118-34. [PMID: 21329698 PMCID: PMC3158665 DOI: 10.1016/j.jmb.2011.02.020] [Citation(s) in RCA: 89] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2010] [Revised: 02/07/2011] [Accepted: 02/09/2011] [Indexed: 11/26/2022]
Abstract
Small heat shock proteins form large cytosolic assemblies from an “α-crystallin domain” (ACD) flanked by sequence extensions. Mutation of a conserved arginine in the ACD of several human small heat shock protein family members causes many common inherited diseases of the lens and neuromuscular system. The mutation R120G in αB-crystallin causes myopathy, cardiomyopathy and cataract. We have solved the X-ray structure of the excised ACD dimer of human αB R120G close to physiological pH and compared it with several recently determined wild-type vertebrate ACD dimer structures. Wild-type excised ACD dimers have a deep groove at the interface floored by a flat extended “bottom sheet.” Solid-state NMR studies of large assemblies of full-length αB-crystallin have shown that the groove is blocked in the ACD dimer by curvature of the bottom sheet. The crystal structure of R120G ACD dimer also reveals a closed groove, but here the bottom sheet is flat. Loss of Arg120 results in rearrangement of an extensive array of charged interactions across this interface. His83 and Asp80 on movable arches on either side of the interface close the groove by forming two new salt bridges. The residues involved in this extended set of ionic interactions are conserved in Hsp27, Hsp20, αA- and αB-crystallin sequences. They are not conserved in Hsp22, where mutation of the equivalent of Arg120 causes neuropathy. We speculate that the αB R120G mutation disturbs oligomer dynamics, causing the growth of large soluble oligomers that are toxic to cells by blocking essential processes.
Collapse
Affiliation(s)
- A R Clark
- Department of Biological Sciences, Crystallography, Institute of Structural and Molecular Biology, Birkbeck College, Malet Street, London WC1E 7HX, UK
| | | | | | | | | |
Collapse
|
23
|
Clark AR, Tawhai MH, Hoffman EA, Burrowes KS. The interdependent contributions of gravitational and structural features to perfusion distribution in a multiscale model of the pulmonary circulation. J Appl Physiol (1985) 2011; 110:943-55. [PMID: 21292845 DOI: 10.1152/japplphysiol.00775.2010] [Citation(s) in RCA: 46] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Recent experimental and imaging studies suggest that the influence of gravity on the measured distribution of blood flow in the lung is largely through deformation of the parenchymal tissue. To study the contribution of hydrostatic effects to regional perfusion in the presence of tissue deformation, we have developed an anatomically structured computational model of the pulmonary circulation (arteries, capillaries, veins), coupled to a continuum model of tissue deformation, and including scale-appropriate fluid dynamics for blood flow in each vessel type. The model demonstrates that both structural and the multiple effects of gravity on the pulmonary circulation make a distinct contribution to the distribution of blood. It shows that postural differences in perfusion gradients can be explained by the combined effect of tissue deformation and extra-acinar blood vessel resistance to flow in the dependent tissue. However, gravitational perfusion gradients persist when the effect of tissue deformation is eliminated, highlighting the importance of the hydrostatic effects of gravity on blood distribution in the pulmonary circulation. Coupling of large- and small-scale models reveals variation in microcirculatory driving pressures within isogravitational planes due to extra-acinar vessel resistance. Variation in driving pressures is due to heterogeneous large-vessel resistance as a consequence of geometric asymmetry in the vascular trees and is amplified by the complex balance of pressures, distension, and flow at the microcirculatory level.
Collapse
Affiliation(s)
- A R Clark
- Auckland Bioengineering Institute, Univ. of Auckland, Private Bag 92019, Auckland Mail Centre, Auckland 1142, New Zealand.
| | | | | | | |
Collapse
|
24
|
Sagransky MJ, Yentzer BA, Williams LL, Clark AR, Taylor SL, Feldman SR. A Randomized Controlled Pilot Study of the Effects of an Extra Office Visit on Adherence and Outcomes in Atopic Dermatitis. ACTA ACUST UNITED AC 2010; 146:1428-30. [DOI: 10.1001/archdermatol.2010.368] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
25
|
Huang WW, Clark AR. Actinic keratosis. Patient-based approaches to adverse event management. Adv NPs PAs 2010; 1:31-49. [PMID: 21319451] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Affiliation(s)
- William W Huang
- Department of Dermatology at Rush University Medical Center, Chicago, USA
| | | |
Collapse
|
26
|
Yentzer BA, Ade RA, Fountain JM, Clark AR, Taylor SL, Borgerding E, Feldman SR. Improvement in treatment adherence with a 3-day course of fluocinonide cream 0.1% for atopic dermatitis. Cutis 2010; 86:208-213. [PMID: 21140931] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Variations in adherence may cause variations in treatment outcomes with topical corticosteroid therapy for atopic dermatitis. An intensive short course of outpatient treatment may promote good adherence and provide a high level of efficacy. The purpose of this study was to assess the efficacy, tolerability, and adherence to short-term treatment with fluocinonide cream 0.1% in the treatment of atopic dermatitis. Twenty participants with mild to severe atopic dermatitis were instructed to use fluocinonide cream 0.1% twice daily for 3 consecutive days for a total of 6 doses. Disease severity was assessed at baseline, day 3, day 7, and day 14. Electronic monitoring was used to measure adherence to treatment. Median adherence to treatment over the 3-day period was 100%. By day 14, the median visual analog scale (VAS) of pruritus and eczema area and severity index (EASI) scores improved from baseline by 79% and 76%, respectively. By the end of the study period, 11 participants had investigator global assessment (IGA) scores of clear or almost clear. The absolute degree of improvement was proportional to baseline disease severity. Short-term treatment with fluocinonide cream 0.1% for atopic dermatitis was well-tolerated and resulted in significant disease improvement (P < .001). Participants were highly adherent to the 3-day treatment regimen. Efforts to improve adherence may be valuable approaches for treating recalcitrant atopic dermatitis.
Collapse
Affiliation(s)
- Brad A Yentzer
- Department of Dermatology, Center for Dermatology Research, Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157-1071, USA.
| | | | | | | | | | | | | |
Collapse
|
27
|
Li F, Zhang M, Hussain F, Triantaphyllopoulos K, Clark AR, Bhavsar PK, Zhou X, Chung KF. Inhibition of p38 MAPK-dependent bronchial contraction after ozone by corticosteroids. Eur Respir J 2010; 37:933-42. [PMID: 20693246 DOI: 10.1183/09031936.00021110] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
We determined the role of p38 mitogen-activated protein kinase (MAPK) in the increased airway smooth muscle (ASM) contractile responses following ozone and modulation by corticosteroids. Mice were exposed to air or ozone (3 ppm for 3 h) and isometric contractile responses of bronchial rings to acetylcholine (ACh) were measured using a myograph in the presence of p38 MAPK inhibitor, SB239063 (10⁻⁶ M) or dexamethasone (10⁻⁶ M). Because MAPK phosphatase (MKP)-1 is a negative regulator of p38 MAPK, we also studied these effects in MKP-1(-/-) mice. Bronchial rings from ozone-exposed wild-type and MKP-1(-/-) mice showed increased contractile responses, with a leftward shift of the dose-response curve in MKP-1(-/-) mice. SB239063 inhibited bronchial contraction equally in air- and ozone-exposed C57/BL6 and MKP-1(-/-) mice. Dexamethasone inhibited ACh-induced bronchial contraction in both air- and ozone-exposed C57/BL6 mice, but not in air- or ozone-exposed MKP-1(-/-) mice. ACh-stimulated p38 MAPK and heat shock protein (HSP)27 phosphorylation, as measured by Western blotting, and this effect was suppressed by SB239063 in C57/BL6 and MKP-1(-/-) mice, but not by dexamethasone in either air- or ozone-exposed MKP-1(-/-) mice. p38 MAPK plays a role in maximal ACh-induced isometric contractile responses and increased contractility induced by ozone. Dexamethasone inhibits ACh-induced ASM contraction through phosphorylation of p38 MAPK and HSP27.
Collapse
Affiliation(s)
- F Li
- Dept Dept of Respiratory Medicine, The Affiliated First People’s Hospital of Shanghai, Jiao Tong University, Shanghai, China
| | | | | | | | | | | | | | | |
Collapse
|
28
|
Yentzer BA, Ade RA, Fountain JM, Clark AR, Taylor SL, Fleischer AB, Feldman SR. Simplifying regimens promotes greater adherence and outcomes with topical acne medications: a randomized controlled trial. Cutis 2010; 86:103-108. [PMID: 20919606] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
New combination topical formulations for the treatment of acne may improve outcomes by increasing adherence. We assessed adherence to and efficacy of a combination topical medication for acne applied once daily compared with daily applications of 2 separate generic subcomponents. Twenty-six participants with mild to moderate acne vulgaris were randomized to 12 weeks of once daily application of clindamycin phosphate 7.2%-tretinoin 0.025% gel (CTG) combination product or separate daily applications of clindamycin phosphate gel 1% and tretinoin cream 0.025% (C gel + T cream) for a total of 2 applications daily. Disease severity was measured at baseline and weeks 4, 8, and 12. Adherence was monitored using electronic monitoring caps on the medication tubes. Of the 26 participants enrolled, 21 completed the 12-week study. Median adherence in the CTG group was 88% compared with 61% in the C gel + T cream group. There was a 51% mean reduction in total lesions for the CTG group versus a 32% mean reduction for the C gel + T cream group by the end of the study. Both CTG and separate applications of C gel + T cream improved mild to moderate acne. The use of a once daily combination product has the advantage of promoting better adherence and clinical outcomes.
Collapse
Affiliation(s)
- Brad A Yentzer
- Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1071, USA
| | | | | | | | | | | | | |
Collapse
|
29
|
Abstract
Sulfanilamide prevents the evolution of an invariably fatal streptococcus empyema in rabbits when it is given repeatedly and in sufficient doses subcutaneously. Complete sterilization of the inoculated cavity occurs on approximately the 2nd day. The serum, defibrinated blood and artificial pleural exudate of similarly treated animals inhibits the growth of the same streptococcus in the test tube but even repeated doses of such treated blood serum fail to sterilize the culture. The coccal chains grown in such drugged serum are elongated and present pleomorphic and metachromatic organisms and may give rise to colonies that are at first less predominantly mucoid in appearance. Such organisms have, however, lost little if any of their virulence. Cooperation on the part of locally derived clasmatocytes is apparently required in complete sterilization of the animal body. This conclusion is reached not only by a process of exclusion from comparison with the test tube results, but through the direct histological demonstration of a precocious and increasing mobilization of clasmatocytes in the parietal and visceral pleura of treated animals. In other words, sulfanilamide apparently produces a bacteriostasis sufficiently marked to protect the accumulated leucocytes and to allow the natural defense macrophages to accumulate. There is direct evidence that the drug does not in itself stimulate the mobilization of the macrophages. There is no evidence that the cell reaction which finally accounts for disposal of the organisms is other than local.
Collapse
Affiliation(s)
- F P Gay
- Department of Bacteriology, College of Physicians and Surgeons, Columbia University, New York
| | | |
Collapse
|
30
|
Clark AR, Burrowes KS, Tawhai MH. Contribution of serial and parallel microperfusion to spatial variability in pulmonary inter- and intra-acinar blood flow. J Appl Physiol (1985) 2010; 108:1116-26. [PMID: 20110543 PMCID: PMC2867543 DOI: 10.1152/japplphysiol.01177.2009] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2009] [Accepted: 01/22/2010] [Indexed: 11/22/2022] Open
Abstract
This study presents a theoretical model of combined series and parallel perfusion in the human pulmonary acinus that maintains computational simplicity while capturing some important features of acinar structure. The model provides a transition between existing models of perfusion in the large pulmonary blood vessels and the pulmonary microcirculation. Arterioles and venules are represented as distinct elastic vessels that follow the branching structure of the acinar airways. These vessels are assumed to be joined at each generation by capillary sheets that cover the alveoli present at that generation, forming a "ladderlike" structure. Compared with a model structure in which capillary beds connect only the most distal blood vessels in the acinus, the model with combined serial and parallel perfusion provides greater capacity for increased blood flow in the lung via capillary recruitment when the blood pressure is elevated. Stratification of acinar perfusion emerges in the model, with red blood cell transit time significantly larger in the distal portion of the acinus compared with the proximal portion. This proximal-to-distal pattern of perfusion may act in concert with diffusional screening to optimize the potential for gas exchange.
Collapse
Affiliation(s)
- A R Clark
- Auckland Bioengineering Institute, University of Auckland, Private Bag 92019, Auckland Mail Centre, Auckland 1142, New Zealand.
| | | | | |
Collapse
|
31
|
Yentzer BA, Camacho FT, Young T, Fountain JM, Clark AR, Feldman SR. Good adherence and early efficacy using desonide hydrogel for atopic dermatitis: results from a program addressing patient compliance. J Drugs Dermatol 2010; 9:324-329. [PMID: 20514788] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
BACKGROUND Patients with atopic dermatitis (AD) may have poor adherence for several reasons, including fear of side effects or dislike of messy topical therapies. PURPOSE To assess adherence to and efficacy of a multifaceted program for atopic dermatitis using a lightweight, easy-to-apply medication and more frequent return visits. METHODS Forty-one subjects with mild-to-moderate atopic dermatitis were instructed to use desonide hydrogel 0.05% twice daily. Disease severity was measured at baseline and weeks 1, 2 and 4. Subjects also received a follow-up phone call on day 3. Adherence was assessed using electronic monitors. At the end of the study, subjects sampled and rated the vehicle attributes of six different topical corticosteroid formulations. RESULTS Mean adherence to twice-daily application slowly declined over time, from 81% on day 1 to 50% by day 27. An improvement in pruritus was observed as early as day 3, and by week 4, mean pruritus and EASI scores improved from baseline by 60% and 61%, respectively. Mean SGA scores also improved to marked improvement/almost clear by week 4. In vehicle attribute surveys, the hydrogel was consistently rated higher than the other vehicles in all categories. CONCLUSION Subjects responded very well to treatment, and adherence to desonide hydrogel 0.05% was much better than previously reported with ointments. The early efficacy, favorable attributes of the hydrogel vehicle and judicious follow up likely increased adherence to topical therapy. The use of ointments or more potent topical steroids as a first choice may be counterproductive in the treatment of atopic dermatitis.
Collapse
Affiliation(s)
- Brad A Yentzer
- Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1071, USA
| | | | | | | | | | | |
Collapse
|
32
|
Wilson R, Camacho F, Clark AR, Young T, Inabinet R, Yentzer BA, Feldman SR. Adherence to topical hydrocortisone 17-butyrate 0.1% in different vehicles in adults with atopic dermatitis. J Am Acad Dermatol 2009; 60:166-8. [DOI: 10.1016/j.jaad.2008.09.031] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2008] [Revised: 09/23/2008] [Accepted: 09/23/2008] [Indexed: 10/21/2022]
|
33
|
Foss CE, Clark AR, Inabinet R, Camacho F, Jorizzo JL. An open-label pilot study of alefacept for the treatment of pyoderma gangrenosum. J Eur Acad Dermatol Venereol 2008; 22:943-9. [DOI: 10.1111/j.1468-3083.2008.02680.x] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
34
|
Abstract
Innate immune responses are critically dependent on MAPK (mitogen-activated protein kinase) signalling pathways, in particular JNK (c-Jun N-terminal kinase) and p38 MAPK. Both of these kinases are negatively regulated via their dephosphorylation by DUSP1 (dual-specificity phosphatase 1). Several pro- and anti-inflammatory stimuli converge to regulate the DUSP1 gene and to modulate the time course of its expression. In turn, the pattern of expression of DUSP1 dictates the kinetics of activation of JNK and p38 MAPK, and this influences the expression of several mediators of innate immunity. DUSP1 is therefore a central regulator of innate immunity, and its expression can profoundly affect the outcome of inflammatory challenges. We discuss possible implications for immune-mediated inflammatory diseases and their treatment.
Collapse
Affiliation(s)
- S M Abraham
- Kennedy Institute of Rheumatology Division, Imperial College London, 1 Aspenlea Road, Hammersmith, London W6 8LH, UK
| | | |
Collapse
|
35
|
Clark AR, Feldman SR, Jorizzo JL. Ultrasonic therapy for psoriasis. J Eur Acad Dermatol Venereol 2006. [DOI: 10.1111/j.1468-3083.1995.tb00286.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
36
|
Abstract
Immature oocytes benefit from nutrient modification of the follicular environment by the surrounding cumulus mass. However, the oxygen concentration that the oocyte may be exposed to could be lower than the antral follicular concentration due to the metabolism of surrounding cumulus cells. Using metabolic data previously determined, we have developed a mathematical model of O2diffusion across the bovine and murine cumulus–oocyte complex. From this we have determined that across a physiological range of external pO2, less than 0.25% and 0.5% O2is removed by cumulus cells within the bovine and murine cumulus–oocyte complex respectively. Our model differs from others as it: incorporates a term that allows for nonlinear variation of the oxygen consumption rate with oxygen concentration; considers two regions (oocyte and cumulus) sharing a common boundary, both of which consume oxygen at different non linear rates. Cumulus cells therefore remove little O2, thus sparing this essential gas for the oocyte, which is dependent on ATP generation via oxidative phosphorylation.
Collapse
Affiliation(s)
- A R Clark
- School of Mathematical Sciences and Research Centre for Reproductive Health, Department of Obstetrics and Gynaecology, The University of Adelaide, SA, Australia
| | | | | | | |
Collapse
|
37
|
Affiliation(s)
- F P Gay
- Department of Bacteriology, Columbia University, New York
| | | |
Collapse
|
38
|
Abazov VM, Abbott B, Abolins M, Acharya BS, Adams DL, Adams M, Adams T, Agelou M, Agram JL, Ahmed SN, Ahn SH, Alexeev GD, Alkhazov G, Alton A, Alverson G, Alves GA, Anastasoaie M, Anderson S, Andrieu B, Arnoud Y, Askew A, Asman B, Atramentov O, Autermann C, Avila C, Babukhadia L, Bacon TC, Badaud F, Baden A, Baffioni S, Baldin B, Balm PW, Banerjee S, Barberis E, Bargassa P, Baringer P, Barnes C, Barreto J, Bartlett JF, Bassler U, Bauer D, Bean A, Beauceron S, Beaudette F, Begel M, Bellavance A, Beri SB, Bernardi G, Bernhard R, Bertram I, Besançon M, Besson A, Beuselinck R, Bezzubov VA, Bhat PC, Bhatnagar V, Bhattacharjee M, Binder M, Bischoff A, Black KM, Blackler I, Blazey G, Blekman F, Blessing S, Bloch D, Blumenschein U, Boehnlein A, Boeriu O, Bolton TA, Bonamy P, Borcherding F, Borissov G, Bos K, Bose T, Boswell C, Brandt A, Briskin G, Brock R, Brooijmans G, Bross A, Buchanan NJ, Buchholz D, Buehler M, Buescher V, Burdin S, Burnett TH, Busato E, Butler JM, Bystricky J, Canelli F, Carvalho W, Casey BCK, Casey D, Cason NM, Castilla-Valdez H, Chakrabarti S, Chakraborty D, Chan KM, Chandra A, Chapin D, Charles F, Cheu E, Chevalier L, Cho DK, Choi S, Chopra S, Christiansen T, Christofek L, Claes D, Clark AR, Clément B, Clément C, Coadou Y, Colling DJ, Coney L, Connolly B, Cooke M, Cooper WE, Coppage D, Corcoran M, Coss J, Cothenet A, Cousinou MC, Crépé-Renaudin S, Cristetiu M, Cummings MAC, Cutts D, da Motta H, Davies B, Davies G, Davis GA, De K, de Jong P, de Jong SJ, De La Cruz-Burelo E, Martins CDO, Dean S, Del Signore K, Déliot F, Delsart PA, Demarteau M, Demina R, Demine P, Denisov D, Denisov SP, Desai S, Diehl HT, Diesburg M, Doidge M, Dong H, Doulas S, Duflot L, Dugad SR, Duperrin A, Dyer J, Dyshkant A, Eads M, Edmunds D, Edwards T, Ellison J, Elmsheuser J, Eltzroth JT, Elvira VD, Eno S, Ermolov P, Eroshin OV, Estrada J, Evans D, Evans H, Evdokimov A, Evdokimov VN, Fast J, Fatakia SN, Fein D, Feligioni L, Ferbel T, Fiedler F, Filthaut F, Fisher W, Fisk HE, Fleuret F, Fortner M, Fox H, Freeman W, Fu S, Fuess S, Galea CF, Gallas E, Galyaev E, Gao M, Garcia C, Garcia-Bellido A, Gardner J, Gavrilov V, Gay P, Gelé D, Gelhaus R, Genser K, Gerber CE, Gershtein Y, Geurkov G, Ginther G, Goldmann K, Golling T, Gómez B, Gounder K, Goussiou A, Graham G, Grannis PD, Greder S, Green JA, Greenlee H, Greenwood ZD, Gregores EM, Grinstein S, Gris P, Grivaz JF, Groer L, Grünendahl S, Grünewald MW, Gu W, Gurzhiev SN, Gutierrez G, Gutierrez P, Haas A, Hadley NJ, Haggerty H, Hagopian S, Hall I, Hall RE, Han C, Han L, Hanagaki K, Hanlet P, Harder K, Harrington R, Hauptman JM, Hauser R, Hays C, Hays J, Hebbeker T, Hebert C, Hedin D, Heinmiller JM, Heinson AP, Heintz U, Hensel C, Hesketh G, Hildreth MD, Hirosky R, Hobbs JD, Hoeneisen B, Hohlfeld M, Hong SJ, Hooper R, Hou S, Houben P, Hu Y, Huang J, Huang Y, Iashvili I, Illingworth R, Ito AS, Jabeen S, Jaffré M, Jain S, Jain V, Jakobs K, Jenkins A, Jesik R, Jiang Y, Johns K, Johnson M, Johnson P, Jonckheere A, Jonsson P, Jöstlein H, Juste A, Kado MM, Käfer D, Kahl W, Kahn S, Kajfasz E, Kalinin AM, Kalk J, Karmanov D, Kasper J, Kau D, Ke Z, Kehoe R, Kermiche S, Kesisoglou S, Khanov A, Kharchilava A, Kharzheev YM, Kim KH, Klima B, Klute M, Kohli JM, Kopal M, Korablev VM, Kotcher J, Kothari B, Kotwal AV, Koubarovsky A, Kouznetsov O, Kozelov AV, Kozminski J, Krane J, Krishnaswamy MR, Krzywdzinski S, Kubantsev M, Kuleshov S, Kulik Y, Kunori S, Kupco A, Kurca T, Kuznetsov VE, Lager S, Lahrichi N, Landsberg G, Lazoflores J, Le Bihan AC, Lebrun P, Lee SW, Lee WM, Leflat A, Leggett C, Lehner F, Leonidopoulos C, Lewis P, Li J, Li QZ, Li X, Lima JGR, Lincoln D, Linn SL, Linnemann J, Lipaev VV, Lipton R, Lobo L, Lobodenko A, Lokajicek M, Lounis A, Lu J, Lubatti HJ, Lucotte A, Lueking L, Luo C, Lynker M, Lyon AL, Maciel AKA, Madaras RJ, Mättig P, Magerkurth A, Magnan AM, Maity M, Makovec N, Mal PK, Malik S, Malyshev VL, Manankov V, Mao HS, Maravin Y, Marshall T, Martens M, Martin MI, Mattingly SEK, Mayorov AA, McCarthy R, McCroskey R, McMahon T, Meder D, Melanson HL, Melnitchouk A, Meng X, Merkin M, Merritt KW, Meyer A, Miao C, Miettinen H, Mihalcea D, Mitrevski J, Mokhov N, Molina J, Mondal NK, Montgomery HE, Moore RW, Mostafa M, Muanza GS, Mulders M, Mutaf YD, Nagy E, Nang F, Narain M, Narasimham VS, Naumann NA, Neal HA, Negret JP, Nelson S, Neustroev P, Noeding C, Nomerotski A, Novaes SF, Nunnemann T, Nurse E, O'Dell V, O'Neil DC, Oguri V, Oliveira N, Olivier B, Oshima N, Otero y Garzón GJ, Padley P, Papageorgiou K, Parashar N, Park J, Park SK, Parsons J, Partridge R, Parua N, Patwa A, Perea PM, Perez E, Peters O, Pétroff P, Petteni M, Phaf L, Piegaia R, Podesta-Lerma PLM, Podstavkov VM, Pogorelov Y, Pope BG, Popkov E, Prado da Silva WL, Prosper HB, Protopopescu S, Przybycien MB, Qian J, Quadt A, Quinn B, Rani KJ, Rapidis PA, Ratoff PN, Reay NW, Renardy JF, Reucroft S, Rha J, Ridel M, Rijssenbeek M, Ripp-Baudot I, Rizatdinova F, Royon C, Rubinov P, Ruchti R, Sabirov BM, Sajot G, Sánchez-Hernández A, Sanders MP, Santoro A, Savage G, Sawyer L, Scanlon T, Schamberger RD, Schellman H, Schieferdecker P, Schmitt C, Schukin AA, Schwartzman A, Schwienhorst R, Sengupta S, Severini H, Shabalina E, Shary V, Shephard WD, Shpakov D, Sidwell RA, Simak V, Sirotenko V, Skow D, Skubic P, Slattery P, Smith RP, Smolek K, Snow GR, Snow J, Snyder S, Söldner-Rembold S, Song X, Song Y, Sonnenschein L, Sopczak A, Sorín V, Sosebee M, Soustruznik K, Souza M, Spurlock B, Stanton NR, Stark J, Steele J, Steinbrück G, Stevenson K, Stolin V, Stone A, Stoyanova DA, Strandberg J, Strang MA, Strauss M, Ströhmer R, Strovink M, Stutte L, Sumowidagdo S, Sznajder A, Talby M, Tamburello P, Taylor W, Telford P, Temple J, Tentindo-Repond S, Thomas E, Thooris B, Tomoto M, Toole T, Torborg J, Towers S, Trefzger T, Trincaz-Duvoid S, Trippe TG, Tuchming B, Tully C, Turcot AS, Tuts PM, Uvarov L, Uvarov S, Uzunyan S, Vachon B, Van Kooten R, van Leeuwen WM, Varelas N, Varnes EW, Vasilyev IA, Vaupel M, Verdier P, Vertogradov LS, Verzocchi M, Villeneuve-Seguier F, Vlimant JR, Von Toerne E, Vreeswijk M, Vu Anh T, Wahl HD, Walker R, Wallace N, Wang ZM, Warchol J, Warsinsky M, Watts G, Wayne M, Weber M, Weerts H, Wegner M, Wermes N, White A, White V, Whiteson D, Wicke D, Wijngaarden DA, Wilson GW, Wimpenny SJ, Wittlin J, Wlodek T, Wobisch M, Womersley J, Wood DR, Wu Z, Wyatt TR, Xu Q, Xuan N, Yamada R, Yan M, Yasuda T, Yatsunenko YA, Yen Y, Yip K, Youn SW, Yu J, Yurkewicz A, Zabi A, Zatserklyaniy A, Zdrazil M, Zeitnitz C, Zhang B, Zhang D, Zhang X, Zhao T, Zhao Z, Zheng H, Zhou B, Zhou Z, Zhu J, Zielinski M, Zieminska D, Zieminski A, Zitoun R, Zutshi V, Zverev EG, Zylberstejn A. Measurement of dijet azimuthal decorrelations at central rapidities in pp collisions at sqrt s =1.96 TeV. Phys Rev Lett 2005; 94:221801. [PMID: 16090381 DOI: 10.1103/physrevlett.94.221801] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/16/2004] [Indexed: 05/03/2023]
Abstract
Correlations in the azimuthal angle between the two largest transverse momentum jets have been measured using the D0 detector in p (-)p collisions at a center-of-mass energy sqrt[s]=1.96 TeV. The analysis is based on an inclusive dijet event sample in the central rapidity region corresponding to an integrated luminosity of 150 pb(-1). Azimuthal correlations are stronger at larger transverse momenta. These are well described in perturbative QCD at next-to-leading order in the strong coupling constant, except at large azimuthal differences where contributions with low transverse momentum are significant.
Collapse
Affiliation(s)
- V M Abazov
- Joint Institute for Nuclear Research, Dubna, Russia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Abazov VM, Abbott B, Abolins M, Acharya BS, Adams DL, Adams M, Adams T, Agelou M, Agram JL, Ahmed SN, Ahn SH, Alexeev GD, Alkhazov G, Alton A, Alverson G, Alves GA, Anderson S, Andrieu B, Arnoud Y, Askew A, Asman B, Atramentov O, Autermann C, Avila C, Babukhadia L, Bacon TC, Baden A, Baffioni S, Baldin B, Balm PW, Banerjee S, Barberis E, Bargassa P, Baringer P, Barnes C, Barreto J, Bartlett JF, Bassler U, Bauer D, Bean A, Beauceron S, Beaudette F, Begel M, Bellavance A, Beri SB, Bernardi G, Bernhard R, Bertram I, Besançon M, Besson A, Beuselinck R, Bezzubov VA, Bhat PC, Bhatnagar V, Bhattacharjee M, Binder M, Bischoff A, Black KM, Blackler I, Blazey G, Blekman F, Bloch D, Blumenschein U, Boehnlein A, Boeriu O, Bolton TA, Bonamy P, Borcherding F, Borissov G, Bos K, Bose T, Boswell C, Brandt A, Briskin G, Brock R, Brooijmans G, Bross A, Buchanan NJ, Buchholz D, Buehler M, Buescher V, Burdin S, Burnett TH, Busato E, Butler JM, Bystricky J, Canelli F, Carvalho W, Casey BCK, Casey D, Cason NM, Castilla-Valdez H, Chakrabarti S, Chakraborty D, Chan KM, Chandra A, Chapin D, Charles F, Cheu E, Chevalier L, Cho DK, Choi S, Chopra S, Christiansen T, Christofek L, Claes D, Clark AR, Clément B, Clément C, Coadou Y, Colling DJ, Coney L, Connolly B, Cooke M, Cooper WE, Coppage D, Corcoran M, Coss J, Cothenet A, Cousinou MC, Crépé-Renaudin S, Cristetiu M, Cummings MAC, Cutts D, da Motta H, Davies B, Davies G, Davis GA, De K, de Jong P, de Jong SJ, De La Cruz-Burelo E, De Oliveira Martins C, Dean S, Del Signore K, Déliot F, Delsart PA, Demarteau M, Demina R, Demine P, Denisov D, Denisov SP, Desai S, Diehl HT, Diesburg M, Doidge M, Dong H, Doulas S, Duflot L, Dugad SR, Duperrin A, Dyer J, Dyshkant A, Eads M, Edmunds D, Edwards T, Ellison J, Elmsheuser J, Eltzroth JT, Elvira VD, Eno S, Ermolov P, Eroshin OV, Estrada J, Evans D, Evans H, Evdokimov A, Evdokimov VN, Fast J, Fatakia SN, Fein D, Feligioni L, Ferbel T, Fiedler F, Filthaut F, Fisher W, Fisk HE, Fleuret F, Fortner M, Fox H, Freeman W, Fu S, Fuess S, Galea CF, Gallas E, Galyaev E, Gao M, Garcia C, Garcia-Bellido A, Gardner J, Gavrilov V, Gelé D, Gelhaus R, Genser K, Gerber CE, Gershtein Y, Geurkov G, Ginther G, Goldmann K, Golling T, Gómez B, Gounder K, Goussiou A, Graham G, Grannis PD, Greder S, Green JA, Greenlee H, Greenwood ZD, Gregores EM, Grinstein S, Grivaz JF, Groer L, Grünendahl S, Grünewald MW, Gu W, Gurzhiev SN, Gutierrez G, Gutierrez P, Haas A, Hadley NJ, Haggerty H, Hagopian S, Hall I, Hall RE, Han C, Han L, Hanagaki K, Hanlet P, Harder K, Harrington R, Hauptman JM, Hauser R, Hays C, Hays J, Hebbeker T, Hebert C, Hedin D, Heinmiller JM, Heinson AP, Heintz U, Hensel C, Hesketh G, Hildreth MD, Hirosky R, Hobbs JD, Hoeneisen B, Hohlfeld M, Hong SJ, Hooper R, Hou S, Hu Y, Huang J, Huang Y, Iashvili I, Illingworth R, Ito AS, Jabeen S, Jaffré M, Jain S, Jain V, Jakobs K, Jenkins A, Jesik R, Jiang Y, Johns K, Johnson M, Johnson P, Jonckheere A, Jonsson P, Jöstlein H, Juste A, Kado MM, Käfer D, Kahl W, Kahn S, Kajfasz E, Kalinin AM, Kalk J, Karmanov D, Kasper J, Kau D, Ke Z, Kehoe R, Kermiche S, Kesisoglou S, Khanov A, Kharchilava A, Kharzheev YM, Kim KH, Klima B, Klute M, Kohli JM, Kopal M, Korablev VM, Kotcher J, Kothari B, Kotwal AV, Koubarovsky A, Kouchner A, Kouznetsov O, Kozelov AV, Kozminski J, Krane J, Krishnaswamy MR, Krzywdzinski S, Kubantsev M, Kuleshov S, Kulik Y, Kunori S, Kupco A, Kurca T, Kuznetsov VE, Lager S, Lahrichi N, Landsberg G, Lazoflores J, Le Bihan AC, Lebrun P, Lee SW, Lee WM, Leflat A, Leggett C, Lehner F, Leonidopoulos C, Lewis P, Li J, Li QZ, Li X, Lima JGR, Lincoln D, Linn SL, Linnemann J, Lipaev VV, Lipton R, Lobo L, Lobodenko A, Lokajicek M, Lounis A, Lu J, Lubatti HJ, Lucotte A, Lueking L, Luo C, Lynker M, Lyon AL, Maciel AKA, Madaras RJ, Mättig P, Magerkurth A, Magnan AM, Maity M, Mal PK, Malik S, Malyshev VL, Manankov V, Mao HS, Maravin Y, Marshall T, Martens M, Martin MI, Mattingly SEK, Mayorov AA, McCarthy R, McCroskey R, McMahon T, Meder D, Melanson HL, Melnitchouk A, Meng X, Merkin M, Merritt KW, Meyer A, Miao C, Miettinen H, Mihalcea D, Mishra CS, Mitrevski J, Mokhov N, Molina J, Mondal NK, Montgomery HE, Moore RW, Mostafa M, Muanza GS, Mulders M, Mutaf YD, Nagy E, Nang F, Narain M, Narasimham VS, Naumann NA, Neal HA, Negret JP, Nelson S, Neustroev P, Noeding C, Nomerotski A, Novaes SF, Nunnemann T, Nurse E, O'Dell V, O'Neil DC, Oguri V, Oliveira N, Olivier B, Oshima N, Otero y Garzón GJ, Padley P, Papageorgiou K, Parashar N, Park J, Park SK, Parsons J, Partridge R, Parua N, Patwa A, Perea PM, Perez E, Peters O, Pétroff P, Petteni M, Phaf L, Piegaia R, Podesta-Lerma PLM, Podstavkov VM, Pope BG, Popkov E, Prado da Silva WL, Prosper HB, Protopopescu S, Przybycien MB, Qian J, Quadt A, Quinn B, Rani KJ, Rapidis PA, Ratoff PN, Reay NW, Renardy JF, Reucroft S, Rha J, Ridel M, Rijssenbeek M, Ripp-Baudot I, Rizatdinova F, Royon C, Rubinov P, Ruchti R, Sabirov BM, Sajot G, Sánchez-Hernández A, Sanders MP, Santoro A, Savage G, Sawyer L, Scanlon T, Schamberger RD, Schellman H, Schieferdecker P, Schmitt C, Schukin AA, Schwartzman A, Schwienhorst R, Sengupta S, Severini H, Shabalina E, Shary V, Shephard WD, Shpakov D, Sidwell RA, Simak V, Sirotenko V, Skow D, Skubic P, Slattery P, Smith RP, Smolek K, Snow GR, Snow J, Snyder S, Söldner-Rembold S, Song X, Song Y, Sonnenschein L, Sopczak A, Sorín V, Sosebee M, Soustruznik K, Souza M, Spurlock B, Stanton NR, Stark J, Steele J, Steinbrück G, Stevenson K, Stolin V, Stone A, Stoyanova DA, Strandberg J, Strang MA, Strauss M, Ströhmer R, Strovink M, Stutte L, Sznajder A, Talby M, Tamburello P, Taylor W, Telford P, Temple J, Tentindo-Repond S, Thomas E, Thooris B, Tomoto M, Toole T, Torborg J, Towers S, Trefzger T, Trincaz-Duvoid S, Trippe TG, Tuchming B, Tully C, Turcot AS, Tuts PM, Uvarov L, Uvarov S, Uzunyan S, Vachon B, Van Kooten R, van Leeuwen WM, Varelas N, Varnes EW, Vasilyev IA, Vaupel M, Verdier P, Vertogradov LS, Verzocchi M, Villeneuve-Seguier F, Vlimant JR, Von Toerne E, Vreeswijk M, Vu Anh T, Wahl HD, Walker R, Wallace N, Wang ZM, Warchol J, Warsinsky M, Watts G, Wayne M, Weber M, Weerts H, Wegner M, Wermes N, White A, White V, Whiteson D, Wicke D, Wijngaarden DA, Wilson GW, Wimpenny SJ, Wittlin J, Wlodek T, Wobisch M, Womersley J, Wood DR, Wu Z, Wyatt TR, Xu Q, Xuan N, Yamada R, Yasuda T, Yatsunenko YA, Yen Y, Yip K, Youn SW, Yu J, Yurkewicz A, Zabi A, Zatserklyaniy A, Zdrazil M, Zeitnitz C, Zhang B, Zhang D, Zhang X, Zhao T, Zhao Z, Zheng H, Zhou B, Zhou Z, Zhu J, Zielinski M, Zieminska D, Zieminski A, Zitoun R, Zutshi V, Zverev EG, Zylberstejn A. Search for supersymmetry with gauge-mediated breaking in diphoton events at D0. Phys Rev Lett 2005; 94:041801. [PMID: 15783547 DOI: 10.1103/physrevlett.94.041801] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/30/2004] [Indexed: 05/24/2023]
Abstract
We report the results of a search for supersymmetry (SUSY) with gauge-mediated breaking in the missing transverse energy distribution of inclusive diphoton events using 263 pb(-1) of data collected by the D0 experiment at the Fermilab Tevatron Collider in 2002-2004. No excess is observed above the background expected from standard model processes, and lower limits on the masses of the lightest neutralino and chargino of about 108 and 195 GeV, respectively, are set at the 95% confidence level. These are the most stringent limits to date for models with gauge-mediated SUSY breaking with a short-lived neutralino as the next-to-lightest SUSY particle.
Collapse
Affiliation(s)
- V M Abazov
- Joint Institute for Nuclear Research, Dubna, Russia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Abazov VM, Abbott B, Abolins M, Acharya BS, Adams DL, Adams M, Adams T, Agelou M, Agram JL, Ahmed SN, Ahn SH, Alexeev GD, Alkhazov G, Alton A, Alverson G, Alves GA, Anastasoaie M, Anderson S, Andrieu B, Arnoud Y, Askew A, Asman B, Atramentov O, Autermann C, Avila C, Babukhadia L, Bacon TC, Badaud F, Baden A, Baffioni S, Baldin B, Balm PW, Banerjee S, Barberis E, Bargassa P, Baringer P, Barnes C, Barreto J, Bartlett JF, Bassler U, Bauer D, Bean A, Beauceron S, Beaudette F, Begel M, Bellavance A, Beri SB, Bernardi G, Bernhard R, Bertram I, Besançon M, Besson A, Beuselinck R, Bezzubov VA, Bhat PC, Bhatnagar V, Bhattacharjee M, Binder M, Bischoff A, Black KM, Blackler I, Blazey G, Blekman F, Blessing S, Bloch D, Blumenschein U, Boehnlein A, Boeriu O, Bolton TA, Bonamy P, Borcherding F, Borissov G, Bos K, Bose T, Boswell C, Brandt A, Briskin G, Brock R, Brooijmans G, Bross A, Buchanan NJ, Buchholz D, Buehler M, Buescher V, Burdin S, Burnett TH, Busato E, Butler JM, Bystricky J, Canelli F, Carvalho W, Casey BCK, Casey D, Cason NM, Castilla-Valdez H, Chakrabarti S, Chakraborty D, Chan KM, Chandra A, Chapin D, Charles F, Cheu E, Chevalier L, Cho DK, Choi S, Chopra S, Christiansen T, Christofek L, Claes D, Clark AR, Clément B, Clément C, Coadou Y, Colling DJ, Coney L, Connolly B, Cooke M, Cooper WE, Coppage D, Corcoran M, Coss J, Cothenet A, Cousinou MC, Crépé-Renaudin S, Cristetiu M, Cummings MAC, Cutts D, da Motta H, Davies B, Davies G, Davis GA, De K, de Jong P, de Jong SJ, De La Cruz-Burelo E, De Oliveira Martins C, Dean S, Del Signore K, Déliot F, Delsart PA, Demarteau M, Demina R, Demine P, Denisov D, Denisov SP, Desai S, Diehl HT, Diesburg M, Doidge M, Dong H, Doulas S, Duflot L, Dugad SR, Duperrin A, Dyer J, Dyshkant A, Eads M, Edmunds D, Edwards T, Ellison J, Elmsheuser J, Eltzroth JT, Elvira VD, Eno S, Ermolov P, Eroshin OV, Estrada J, Evans D, Evans H, Evdokimov A, Evdokimov VN, Fast J, Fatakia SN, Fein D, Feligioni L, Ferbel T, Fiedler F, Filthaut F, Fisher W, Fisk HE, Fleuret F, Fortner M, Fox H, Freeman W, Fu S, Fuess S, Galea CF, Gallas E, Galyaev E, Gao M, Garcia C, Garcia-Bellido A, Gardner J, Gavrilov V, Gay P, Gelé D, Gelhaus R, Genser K, Gerber CE, Gershtein Y, Geurkov G, Ginther G, Goldmann K, Golling T, Gómez B, Gounder K, Goussiou A, Graham G, Grannis PD, Greder S, Green JA, Greenlee H, Greenwood ZD, Gregores EM, Grinstein S, Gris P, Grivaz JF, Groer L, Grünendahl S, Grünewald MW, Gu W, Gurzhiev SN, Gutierrez G, Gutierrez P, Haas A, Hadley NJ, Haggerty H, Hagopian S, Hall I, Hall RE, Han C, Han L, Hanagaki K, Hanlet P, Harder K, Harrington R, Hauptman JM, Hauser R, Hays C, Hays J, Hebbeker T, Hebert C, Hedin D, Heinmiller JM, Heinson AP, Heintz U, Hensel C, Hesketh G, Hildreth MD, Hirosky R, Hobbs JD, Hoeneisen B, Hohlfeld M, Hong SJ, Hooper R, Hou S, Houben P, Hu Y, Huang J, Huang Y, Iashvili I, Illingworth R, Ito AS, Jabeen S, Jaffré M, Jain S, Jain V, Jakobs K, Jenkins A, Jesik R, Jiang Y, Johns K, Johnson M, Johnson P, Jonckheere A, Jonsson P, Jöstlein H, Juste A, Kado MM, Käfer D, Kahl W, Kahn S, Kajfasz E, Kalinin AM, Kalk J, Karmanov D, Kasper J, Kau D, Ke Z, Kehoe R, Kermiche S, Kesisoglou S, Khanov A, Kharchilava A, Kharzheev YM, Kim KH, Klima B, Klute M, Kohli JM, Kopal M, Korablev VM, Kotcher J, Kothari B, Kotwal AV, Koubarovsky A, Kouznetsov O, Kozelov AV, Kozminski J, Krane J, Krishnaswamy MR, Krzywdzinski S, Kubantsev M, Kuleshov S, Kulik Y, Kunori S, Kupco A, Kurca T, Kuznetsov VE, Lager S, Lahrichi N, Landsberg G, Lazoflores J, Le Bihan AC, Lebrun P, Lee SW, Lee WM, Leflat A, Leggett C, Lehner F, Leonidopoulos C, Lewis P, Li J, Li QZ, Li X, Lima JGR, Lincoln D, Linn SL, Linnemann J, Lipaev VV, Lipton R, Lobo L, Lobodenko A, Lokajicek M, Lounis A, Lu J, Lubatti HJ, Lucotte A, Lueking L, Luo C, Lynker M, Lyon AL, Maciel AKA, Madaras RJ, Mättig P, Magerkurth A, Magnan AM, Maity M, Makovec N, Mal PK, Malik S, Malyshev VL, Manankov V, Mao HS, Maravin Y, Marshall T, Martens M, Martin MI, Mattingly SEK, Mayorov AA, McCarthy R, McCroskey R, McMahon T, Meder D, Melanson HL, Melnitchouk A, Meng X, Merkin M, Merritt KW, Meyer A, Miao C, Miettinen H, Mihalcea D, Mitrevski J, Mokhov N, Molina J, Mondal NK, Montgomery HE, Moore RW, Mostafa M, Muanza GS, Mulders M, Mutaf YD, Nagy E, Nang F, Narain M, Narasimham VS, Naumann NA, Neal HA, Negret JP, Nelson S, Neustroev P, Noeding C, Nomerotski A, Novaes SF, Nunnemann T, Nurse E, O'Dell V, O'Neil DC, Oguri V, Oliveira N, Olivier B, Oshima N, Otero y Garzón GJ, Padley P, Papageorgiou K, Parashar N, Park J, Park SK, Parsons J, Partridge R, Parua N, Patwa A, Perea PM, Perez E, Peters O, Pétroff P, Petteni M, Phaf L, Piegaia R, Podesta-Lerma PLM, Podstavkov VM, Pogorelov Y, Pope BG, Popkov E, Prado da Silva WL, Prosper HB, Protopopescu S, Przybycien MB, Qian J, Quadt A, Quinn B, Rani KJ, Rapidis PA, Ratoff PN, Reay NW, Renardy JF, Reucroft S, Rha J, Ridel M, Rijssenbeek M, Ripp-Baudot I, Rizatdinova F, Royon C, Rubinov P, Ruchti R, Sabirov BM, Sajot G, Sánchez-Hernández A, Sanders MP, Santoro A, Savage G, Sawyer L, Scanlon T, Schamberger RD, Schellman H, Schieferdecker P, Schmitt C, Schukin AA, Schwartzman A, Schwienhorst R, Sengupta S, Severini H, Shabalina E, Shary V, Shephard WD, Shpakov D, Sidwell RA, Simak V, Sirotenko V, Skow D, Skubic P, Slattery P, Smith RP, Smolek K, Snow GR, Snow J, Snyder S, Söldner-Rembold S, Song X, Song Y, Sonnenschein L, Sopczak A, Sorín V, Sosebee M, Soustruznik K, Souza M, Spurlock B, Stanton NR, Stark J, Steele J, Steinbrück G, Stevenson K, Stolin V, Stone A, Stoyanova DA, Strandberg J, Strang MA, Strauss M, Ströhmer R, Strovink M, Stutte L, Sumowidagdo S, Sznajder A, Talby M, Tamburello P, Taylor W, Telford P, Temple J, Tentindo-Repond S, Thomas E, Thooris B, Tomoto M, Toole T, Torborg J, Towers S, Trefzger T, Trincaz-Duvoid S, Trippe TG, Tuchming B, Tully C, Turcot AS, Tuts PM, Uvarov L, Uvarov S, Uzunyan S, Vachon B, Van Kooten R, van Leeuwen WM, Varelas N, Varnes EW, Vasilyev IA, Vaupel M, Verdier P, Vertogradov LS, Verzocchi M, Villeneuve-Seguier F, Von Vlimant JR, Toerne E, Vreeswijk M, Vu Anh T, Wahl HD, Walker R, Wallace N, Wang ZM, Warchol J, Warsinsky M, Watts G, Wayne M, Weber M, Weerts H, Wegner M, Wermes N, White A, White V, Whiteson D, Wicke D, Wijngaarden DA, Wilson GW, Wimpenny SJ, Wittlin J, Wlodek T, Wobisch M, Womersley J, Wood DR, Wu Z, Wyatt TR, Xu Q, Xuan N, Yamada R, Yan M, Yasuda T, Yatsunenko YA, Yen Y, Yip K, Youn SW, Yu J, Yurkewicz A, Zabi A, Zatserklyaniy A, Zdrazil M, Zeitnitz C, Zhang B, Zhang D, Zhang X, Zhao T, Zhao Z, Zheng H, Zhou B, Zhou Z, Zhu J, Zielinski M, Zieminska D, Zieminski A, Zitoun R, Zutshi V, Zverev EG, Zylberstejn A. Measurement of the B0s lifetime in the exclusive decay channel B0s-->J/psiphi. Phys Rev Lett 2005; 94:042001. [PMID: 15783550 DOI: 10.1103/physrevlett.94.042001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/22/2004] [Indexed: 05/24/2023]
Abstract
Using the exclusive decay B0s-->J/psi(mu+mu-)phi(K+K-), we report the most precise single measurement of the B0s lifetime. The data sample corresponds to an integrated luminosity of approximately 220 pb(-1) collected with the D0 detector at the Fermilab Tevatron Collider in 2002-2004. We reconstruct 337 signal candidates, from which we extract the B0s lifetime, tau(B0s)=1.444(+0.098)(-0.090)(stat)+/-0.020(sys) ps. We also report a measurement for the lifetime of the B0 meson using the exclusive decay B0-->J/psi(mu+mu-)K*0(892)(K+pi-). We reconstruct 1370 signal candidates, obtaining tau(B0)=1.473(+0.052)(-0.050)(stat)+/-0.023(sys) ps, and the ratio of lifetimes, tau(B0s)/tau(B0)=0.980(+0.076)(-0.071)(stat)+/-0.003(sys).
Collapse
Affiliation(s)
- V M Abazov
- Joint Institute for Nuclear Research, Dubna, Russia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
41
|
Feldman SR, Clark AR, Venkat AP, Fleischer AB, Anderson RT, Rajagopalan R. The Self-Administered Psoriasis Area and Severity Index provides an objective measure of psoriasis severity. Br J Dermatol 2005; 152:382-3. [PMID: 15727666 DOI: 10.1111/j.1365-2133.2005.06351.x] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
42
|
Khoury M, Apparailly F, Clark A, Plence P, Noel D, Jorgensen C. Arthritis Res Ther 2005; 7:P71. [DOI: 10.1186/ar1592] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
43
|
Abazov VM, Abbott B, Abolins M, Acharya BS, Adams DL, Adams M, Adams T, Agelou M, Agram JL, Ahmed SN, Ahn SH, Alexeev GD, Alkhazov G, Alton A, Alverson G, Alves GA, Anderson S, Andrieu B, Arnoud Y, Askew A, Asman B, Autermann C, Avila C, Babukhadia L, Bacon TC, Baden A, Baffioni S, Baldin B, Balm PW, Banerjee S, Barberis E, Bargassa P, Baringer P, Barnes C, Barreto J, Bartlett JF, Bassler U, Bauer D, Bean A, Beauceron S, Beaudette F, Begel M, Beri SB, Bernardi G, Bertram I, Besançon M, Besson A, Beuselinck R, Bezzubov VA, Bhat PC, Bhatnagar V, Bhattacharjee M, Binder M, Bischoff A, Black KM, Blackler I, Blazey G, Blekman F, Bloch D, Blumenschein U, Boehnlein A, Bolton TA, Bonamy P, Borcherding F, Borissov G, Bos K, Bose T, Boswell C, Brandt A, Briskin G, Brock R, Brooijmans G, Bross A, Buchholz D, Buehler M, Buescher V, Burdin S, Burnett TH, Busato E, Butler JM, Bystricky J, Canelli F, Carvalho W, Casey BCK, Casey D, Cason NM, Castilla-Valdez H, Chakrabarti S, Chakraborty D, Chan KM, Chandra A, Chapin D, Charles F, Cheu E, Chevalier L, Cho DK, Choi S, Chopra S, Christiansen T, Christofek L, Claes D, Clark AR, Clément C, Coadou Y, Colling DJ, Coney L, Connolly B, Cooper WE, Coppage D, Corcoran M, Coss J, Cothenet A, Cousinou MC, Crépé-Renaudin S, Cristetiu M, Cummings MAC, Cutts D, da Motta H, Davies B, Davies G, Davis GA, De K, de Jong P, de Jong SJ, De La Cruz-Burelo E, De Oliveira Martins C, Dean S, Del Signore K, Déliot F, Delsart PA, Demarteau M, Demina R, Demine P, Denisov D, Denisov SP, Desai S, Diehl HT, Diesburg M, Doidge M, Dong H, Doulas S, Duflot L, Dugad SR, Duperrin A, Dyer J, Dyshkant A, Eads M, Edmunds D, Edwards T, Ellison J, Elmsheuser J, Eltzroth JT, Elvira VD, Eno S, Ermolov P, Eroshin OV, Estrada J, Evans D, Evans H, Evdokimov A, Evdokimov VN, Fast J, Fatakia SN, Fein D, Feligioni L, Ferbel T, Fiedler F, Filthaut F, Fisk HE, Fleuret F, Fortner M, Fox H, Freeman W, Fu S, Fuess S, Galea CF, Gallas E, Galyaev E, Gao M, Garcia C, Garcia-Bellido A, Gardner J, Gavrilov V, Gelé D, Gelhaus R, Genser K, Gerber CE, Gershtein Y, Geurkov G, Ginther G, Goldmann K, Golling T, Gómez B, Gounder K, Goussiou A, Graham G, Grannis PD, Greder S, Green JA, Greenlee H, Greenwood ZD, Gregores EM, Grinstein S, Grivaz JF, Groer L, Grünendahl S, Grünewald MW, Gu W, Gurzhiev SN, Gutierrez G, Gutierrez P, Haas A, Hadley NJ, Haggerty H, Hagopian S, Hall I, Hall RE, Han C, Han L, Hanagaki K, Hanlet P, Harder K, Hauptman JM, Hauser R, Hays C, Hays J, Hebert C, Hedin D, Heinmiller JM, Heinson AP, Heintz U, Hensel C, Hesketh G, Hildreth MD, Hirosky R, Hobbs JD, Hoeneisen B, Hohlfeld M, Hong SJ, Hooper R, Hou S, Hu Y, Huang J, Huang Y, Iashvili I, Illingworth R, Ito AS, Jabeen S, Jaffré M, Jain S, Jain V, Jakobs K, Jenkins A, Jesik R, Jiang Y, Johns K, Johnson M, Johnson P, Jonckheere A, Jonsson P, Jöstlein H, Juste A, Kado MM, Käfer D, Kahl W, Kahn S, Kajfasz E, Kalinin AM, Kalk J, Karmanov D, Kasper J, Kau D, Ke Z, Kehoe R, Kermiche S, Kesisoglou S, Khanov A, Kharchilava A, Kharzheev YM, Kim KH, Klima B, Klute M, Kohli JM, Kopal M, Korablev V, Kotcher J, Kothari B, Kotwal AV, Koubarovsky A, Kouchner A, Kouznetsov O, Kozelov AV, Kozminski J, Krane J, Krishnaswamy MR, Krzywdzinski S, Kubantsev M, Kuleshov S, Kulik Y, Kunori S, Kupco A, Kurca T, Kuznetsov VE, Lager S, Lahrichi N, Landsberg G, Lazoflores J, Le Bihan AC, Lebrun P, Lee SW, Lee WM, Leflat A, Leggett C, Lehner F, Leonidopoulos C, Lewis P, Li J, Li QZ, Li X, Lima JGR, Lincoln D, Linn SL, Linnemann J, Lipton R, Lobo L, Lobodenko A, Lokajicek M, Lounis A, Lu J, Lubatti HJ, Lucotte A, Lueking L, Luo C, Lynker M, Lyon AL, Maciel AKA, Madaras RJ, Mättig P, Magnan AM, Maity M, Mal PK, Malik S, Malyshev VL, Manankov V, Mao HS, Maravin Y, Marshall T, Martens M, Martin MI, Mattingly SEK, Mayorov AA, McCarthy R, McCroskey R, McMahon T, Meder D, Melanson HL, Melnitchouk A, Meng X, Merkin M, Merritt KW, Meyer A, Miao C, Miettinen H, Mihalcea D, Mishra CS, Mitrevski J, Mokhov N, Molina J, Mondal NK, Montgomery HE, Moore RW, Mostafa M, Muanza GS, Mulders M, Mutaf YD, Nagy E, Nang F, Narain M, Narasimham VS, Naumann NA, Neal HA, Negret JP, Nelson S, Neustroev P, Noeding C, Nomerotski A, Novaes SF, Nunnemann T, Nurse E, O'Dell V, O'Neil DC, Oguri V, Oliveira N, Olivier B, Oshima N, Otero y Garzón GJ, Padley P, Papageorgiou K, Parashar N, Park J, Park SK, Parsons J, Partridge R, Parua N, Patwa A, Perea PM, Perez E, Peters O, Pétroff P, Petteni M, Phaf L, Piegaia R, Podesta-Lerma PLM, Podstavkov VM, Pope BG, Popkov E, Prado da Silva WL, Prosper HB, Protopopescu S, Przybycien MB, Qian J, Quadt A, Quinn B, Rani KJ, Rapidis PA, Ratoff PN, Reay NW, Renardy JF, Reucroft S, Rha J, Ridel M, Rijssenbeek M, Ripp-Baudot I, Rizatdinova F, Royon C, Rubinov P, Ruchti R, Sabirov BM, Sajot G, Sánchez-Hernández A, Sanders MP, Santoro A, Savage G, Sawyer L, Scanlon T, Schamberger RD, Schellman H, Schieferdecker P, Schmitt C, Schukin A, Schwartzman A, Schwienhorst R, Sengupta S, Shabalina E, Shary V, Shephard WD, Shpakov D, Sidwell RA, Simak V, Sirotenko V, Skow D, Slattery P, Smith RP, Smolek K, Snow GR, Snow J, Snyder S, Söldner-Rembold S, Song X, Song Y, Sonnenschein L, Sopczak A, Sorín V, Sosebee M, Soustruznik K, Souza M, Stanton NR, Stark J, Steele J, Steinbrück G, Stevenson K, Stolin V, Stone A, Stoyanova DA, Strandberg J, Strang MA, Strauss M, Ströhmer R, Strovink M, Stutte L, Sznajder A, Talby M, Tamburello P, Taylor W, Telford P, Temple J, Tentindo-Repond S, Thomas E, Thooris B, Tomoto M, Toole T, Torborg J, Towers S, Trefzger T, Trincaz-Duvoid S, Trippe TG, Tuchming B, Tully C, Turcot AS, Tuts PM, Uvarov L, Uvarov S, Uzunyan S, Vachon B, Van Kooten R, van Leeuwen WM, Varelas N, Varnes EW, Vasilyev I, Vaupel M, Verdier P, Vertogradov LS, Verzocchi M, Villeneuve-Seguier F, Vlimant JR, Von Toerne E, Vreeswijk M, Vu Anh T, Wahl HD, Walker R, Wallace N, Wang ZM, Warchol J, Warsinsky M, Watts G, Wayne M, Weber M, Weerts H, Wegner M, White A, White V, Whiteson D, Wicke D, Wijngaarden DA, Wilson GW, Wimpenny SJ, Wittlin J, Wlodek T, Wobisch M, Womersley J, Wood DR, Wu Z, Wyatt TR, Xu Q, Xuan N, Yamada R, Yasuda T, Yatsunenko YA, Yen Y, Yip K, Youn SW, Yu J, Yurkewicz A, Zabi A, Zatserklyaniy A, Zdrazil M, Zeitnitz C, Zhang B, Zhang D, Zhang X, Zhao T, Zhao Z, Zheng H, Zhou B, Zhou Z, Zhu J, Zielinski M, Zieminska D, Zieminski A, Zitoun R, Zutshi V, Zverev EG, Zylberstejn A. Observation and properties of the X(3872) decaying to J/psipi(+)pi(-) in pp collisions at sqrt[s]=1.96 TeV. Phys Rev Lett 2004; 93:162002. [PMID: 15524981 DOI: 10.1103/physrevlett.93.162002] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/05/2004] [Indexed: 05/24/2023]
Abstract
We report the observation of the X(3872) in the J/psipi(+)pi(-) channel, with J/psi decaying to mu(+)mu(-), in pp collisions at sqrt[s]=1.96 TeV. Using approximately 230 pb(-1) of data collected with the Run II D0 detector, we observe 522+/-100 X(3872) candidates. The mass difference between the X(3872) state and the J/psi is measured to be 774.9+/-3.1(stat)+/-3.0(syst) MeV/c(2). We have investigated the production and decay characteristics of the X(3872) and find them to be similar to those of the psi(2S) state.
Collapse
Affiliation(s)
- V M Abazov
- Joint Institute for Nuclear Research, Dubna, Russia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Abazov VM, Abbott B, Abolins M, Acharya BS, Adams DL, Adams M, Adams T, Agelou M, Agram JL, Ahmed SN, Ahn SH, Alexeev GD, Alkhazov G, Alton A, Alverson G, Alves GA, Anderson S, Andrieu B, Arnoud Y, Askew A, Asman B, Autermann C, Avila C, Babukhadia L, Bacon TC, Baden A, Baffioni S, Baldin B, Balm PW, Banerjee S, Barberis E, Bargassa P, Baringer P, Barnes C, Barreto J, Bartlett JF, Bassler U, Bauer D, Bean A, Beauceron S, Beaudette F, Begel M, Beri SB, Bernardi G, Bertram I, Besançon M, Besson A, Beuselinck R, Bezzubov VA, Bhat PC, Bhatnagar V, Bhattacharjee M, Binder M, Bischoff A, Black KM, Blackler I, Blazey G, Blekman F, Bloch D, Blumenschein U, Boehnlein A, Bolton TA, Bonamy P, Borcherding F, Borissov G, Bos K, Bose T, Boswell C, Brandt A, Briskin G, Brock R, Brooijmans G, Bross A, Buchholz D, Buehler M, Buescher V, Burdin S, Burnett TH, Busato E, Butler JM, Bystricky J, Canelli F, Carvalho W, Casey BCK, Casey D, Cason NM, Castilla-Valdez H, Chakrabarti S, Chakraborty D, Chan KM, Chandra A, Chapin D, Charles F, Cheu E, Chevalier L, Cho DK, Choi S, Chopra S, Christiansen T, Christofek L, Claes D, Clark AR, Clément C, Coadou Y, Colling DJ, Coney L, Connolly B, Cooper WE, Coppage D, Corcoran M, Coss J, Cothenet A, Cousinou MC, Crépé-Renaudin S, Cristetiu M, Cummings MAC, Cutts D, da Motta H, Davies B, Davies G, Davis GA, De K, de Jong P, de Jong SJ, De La Cruz-Burelo E, De Oliveira Martins C, Dean S, Del Signore K, Déliot F, Delsart PA, Demarteau M, Demina R, Demine P, Denisov D, Denisov SP, Desai S, Diehl HT, Diesburg M, Doidge M, Dong H, Doulas S, Duflot L, Dugad SR, Duperrin A, Dyer J, Dyshkant A, Eads M, Edmunds D, Edwards T, Ellison J, Elmsheuser J, Eltzroth JT, Elvira VD, Eno S, Ermolov P, Eroshin OV, Estrada J, Evans D, Evans H, Evdokimov A, Evdokimov VN, Fast J, Fatakia SN, Fein D, Feligioni L, Ferbel T, Fiedler F, Filthaut F, Fisk HE, Fleuret F, Fortner M, Fox H, Freeman W, Fu S, Fuess S, Galea CF, Gallas E, Galyaev E, Gao M, Garcia C, Garcia-Bellido A, Gardner J, Gavrilov V, Gelé D, Gelhaus R, Genser K, Gerber CE, Gershtein Y, Geurkov G, Ginther G, Goldmann K, Golling T, Gómez B, Gounder K, Goussiou A, Graham G, Grannis PD, Greder S, Green JA, Greenlee H, Greenwood ZD, Gregores EM, Grinstein S, Grivaz JF, Groer L, Grünendahl S, Grünewald MW, Gu W, Gurzhiev SN, Gutierrez G, Gutierrez P, Haas A, Hadley NJ, Haggerty H, Hagopian S, Hall I, Hall RE, Han C, Han L, Hanagaki K, Hanlet P, Harder K, Hauptman JM, Hauser R, Hays C, Hays J, Hebert C, Hedin D, Heinmiller JM, Heinson AP, Heintz U, Hensel C, Hesketh G, Hildreth MD, Hirosky R, Hobbs JD, Hoeneisen B, Hohlfeld M, Hong SJ, Hooper R, Hou S, Hu Y, Huang J, Huang Y, Iashvili I, Illingworth R, Ito AS, Jabeen S, Jaffré M, Jain S, Jain V, Jakobs K, Jenkins A, Jesik R, Jiang Y, Johns K, Johnson M, Johnson P, Jonckheere A, Jonsson P, Jöstlein H, Juste A, Kado MM, Käfer D, Kahl W, Kahn S, Kajfasz E, Kalinin AM, Kalk J, Karmanov D, Kasper J, Kau D, Ke Z, Kehoe R, Kermiche S, Kesisoglou S, Khanov A, Kharchilava A, Kharzheev YM, Kim KH, Klima B, Klute M, Kohli JM, Kopal M, Korablev V, Kotcher J, Kothari B, Kotwal AV, Koubarovsky A, Kouchner A, Kouznetsov O, Kozelov AV, Kozminski J, Krane J, Krishnaswamy MR, Krzywdzinski S, Kubantsev M, Kuleshov S, Kulik Y, Kunori S, Kupco A, Kurca T, Kuznetsov VE, Lager S, Lahrichi N, Landsberg G, Lazoflores J, Le Bihan AC, Lebrun P, Lee SW, Lee WM, Leflat A, Leggett C, Lehner F, Leonidopoulos C, Lewis P, Li J, Li QZ, Li X, Lima JGR, Lincoln D, Linn SL, Linnemann J, Lipton R, Lobo L, Lobodenko A, Lokajicek M, Lounis A, Lu J, Lubatti HJ, Lucotte A, Lueking L, Luo C, Lynker M, Lyon AL, Maciel AKA, Madaras RJ, Magnan AM, Maity M, Mal PK, Malik S, Malyshev VL, Manankov V, Mao HS, Maravin Y, Marshall T, Martens M, Martin MI, Mattingly SEK, Mayorov AA, McCarthy R, McCroskey R, McMahon T, Meder D, Melanson HL, Melnitchouk A, Meng X, Merkin M, Merritt KW, Meyer A, Miao C, Miettinen H, Mihalcea D, Mishra CS, Mitrevski J, Mokhov N, Molina J, Mondal NK, Montgomery HE, Moore RW, Mostafa M, Muanza GS, Mulders M, Mutaf YD, Nagy E, Nang F, Narain M, Narasimham VS, Naumann NA, Neal HA, Negret JP, Nelson S, Neustroev P, Noeding C, Nomerotski A, Novaes SF, Nunnemann T, Nurse E, O'Dell V, O'Neil DC, Oguri V, Oliveira N, Olivier B, Oshima N, Otero y Garzón GJ, Padley P, Papageorgiou K, Parashar N, Park J, Park SK, Parsons J, Partridge R, Parua N, Patwa A, Perea PM, Perez E, Peters O, Pétroff P, Petteni M, Phaf L, Piegaia R, Podesta-Lerma PLM, Podstavkov VM, Pope BG, Popkov E, Prado da Silva WL, Prosper HB, Protopopescu S, Przybycien MB, Qian J, Quadt A, Quinn B, Rani KJ, Rapidis PA, Ratoff PN, Reay NW, Renardy JF, Reucroft S, Rha J, Ridel M, Rijssenbeek M, Ripp-Baudot I, Rizatdinova F, Royon C, Rubinov P, Ruchti R, Sabirov BM, Sajot G, Sánchez-Hernández A, Sanders MP, Santoro A, Savage G, Sawyer L, Scanlon T, Schamberger RD, Schellman H, Schieferdecker P, Schmitt C, Schukin A, Schwartzman A, Schwienhorst R, Sengupta S, Shabalina E, Shary V, Shephard WD, Shpakov D, Sidwell RA, Simak V, Sirotenko V, Skow D, Slattery P, Smith RP, Smolek K, Snow GR, Snow J, Snyder S, Söldner-Rembold S, Song X, Song Y, Sonnenschein L, Sopczak A, Sorín V, Sosebee M, Soustruznik K, Souza M, Stanton NR, Stark J, Steele J, Steinbrück G, Stevenson K, Stolin V, Stone A, Stoyanova DA, Strandberg J, Strang MA, Strauss M, Ströhmer R, Strovink M, Stutte L, Sznajder A, Talby M, Tamburello P, Taylor W, Telford P, Temple J, Tentindo-Repond S, Thomas E, Thooris B, Tomoto M, Toole T, Torborg J, Towers S, Trefzger T, Trincaz-Duvoid S, Trippe TG, Tuchming B, Turcot AS, Tuts PM, Uvarov L, Uvarov S, Uzunyan S, Vachon B, Van Kooten R, van Leeuwen WM, Varelas N, Varnes EW, Vasilyev I, Verdier P, Vertogradov LS, Verzocchi M, Villeneuve-Seguier F, Vlimant JR, Von Toerne E, Vreeswijk M, Vu Anh T, Wahl HD, Walker R, Wallace N, Wang ZM, Warchol J, Warsinsky M, Watts G, Wayne M, Weber M, Weerts H, Wegner M, White A, White V, Whiteson D, Wicke D, Wijngaarden DA, Wilson GW, Wimpenny SJ, Wittlin J, Wlodek T, Wobisch M, Womersley J, Wood DR, Wu Z, Wyatt TR, Xu Q, Xuan N, Yamada R, Yasuda T, Yatsunenko YA, Yen Y, Yip K, Youn SW, Yu J, Yurkewicz A, Zabi A, Zatserklyaniy A, Zdrazil M, Zeitnitz C, Zhang B, Zhang D, Zhang X, Zhao T, Zhao Z, Zheng H, Zhou B, Zhou Z, Zhu J, Zielinski M, Zieminska D, Zieminski A, Zitoun R, Zutshi V, Zverev EG, Zylberstejn A. Search for doubly charged higgs boson pair production in the decay to mu(+)mu(+)mu(-)mu(-) in pp collisions at sqrt[s]=1.96 TeV. Phys Rev Lett 2004; 93:141801. [PMID: 15524781 DOI: 10.1103/physrevlett.93.141801] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/09/2004] [Indexed: 05/24/2023]
Abstract
A search for pair production of doubly charged Higgs bosons in the process pp -->H(++)H(--) -->mu(+)mu(+)mu(-)mu(-) is performed with the D0 run II detector at the Fermilab Tevatron. The analysis is based on a sample of inclusive dimuon data collected at an energy of sqrt[s]=1.96 TeV, corresponding to an integrated luminosity of 113 pb(-1). In the absence of a signal, 95% confidence level mass limits of M(H(+/-+/-)(L))>118.4 GeV/c(2) and M(H(+/-+/-)(R))>98.2 GeV/c(2) are set for left-handed and right-handed doubly charged Higgs bosons, respectively, assuming 100% branching into muon pairs.
Collapse
Affiliation(s)
- V M Abazov
- Joint Institute for Nuclear Research, Dubna, Russia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Abazov VM, Abbott B, Abdesselam A, Abolins M, Abramov V, Acharya BS, Adams DL, Adams M, Ahmed SN, Alexeev GD, Alton A, Alves GA, Arnoud Y, Avila C, Babintsev VV, Babukhadia L, Bacon TC, Baden A, Baffioni S, Baldin B, Balm PW, Banerjee S, Barberis E, Baringer P, Barreto J, Bartlett JF, Bassler U, Bauer D, Bean A, Beaudette F, Begel M, Belyaev A, Beri SB, Bernardi G, Bertram I, Besson A, Beuselinck R, Bezzubov VA, Bhat PC, Bhatnagar V, Bhattacharjee M, Blazey G, Blekman F, Blessing S, Boehnlein A, Bojko NI, Bolton TA, Borcherding F, Bos K, Bose T, Brandt A, Briskin G, Brock R, Brooijmans G, Bross A, Buchholz D, Buehler M, Buescher V, Burtovoi VS, Butler JM, Canelli F, Carvalho W, Casey D, Castilla-Valdez H, Chakraborty D, Chan KM, Chekulaev SV, Cho DK, Choi S, Chopra S, Claes D, Clark AR, Connolly B, Cooper WE, Coppage D, Crépé-Renaudin S, Cummings MAC, Cutts D, Da Motta H, Davis GA, De K, De Jong SJ, Demarteau M, Demina R, Demine P, Denisov D, Denisov SP, Desai S, Diehl HT, Diesburg M, Doulas S, Dudko LV, Duflot L, Dugad SR, Duperrin A, Dyshkant A, Edmunds D, Ellison J, Eltzroth JT, Elvira VD, Engelmann R, Eno S, Eppley G, Ermolov P, Eroshin OV, Estrada J, Evans H, Evdokimov VN, Ferbel T, Filthaut F, Fisk HE, Fortner M, Fox H, Fu S, Fuess S, Gallas E, Galyaev AN, Gao M, Gavrilov V, Genik RJ, Genser K, Gerber CE, Gershtein Y, Ginther G, Gómez B, Goncharov PI, Gounder K, Goussiou A, Grannis PD, Greenlee H, Greenwood ZD, Grinstein S, Groer L, Grünendahl S, Grünewald MW, Gurzhiev SN, Gutierrez G, Gutierrez P, Hadley NJ, Haggerty H, Hagopian S, Hagopian V, Hall RE, Han C, Hansen S, Hauptman JM, Hebert C, Hedin D, Heinmiller JM, Heinson AP, Heintz U, Hildreth MD, Hirosky R, Hobbs JD, Hoeneisen B, Huang J, Huang Y, Iashvili I, Illingworth R, Ito AS, Jaffré M, Jain S, Jesik R, Johns K, Johnson M, Jonckheere A, Jöstlein H, Juste A, Kahl W, Kahn S, Kajfasz E, Kalinin AM, Karmanov D, Karmgard D, Kehoe R, Kesisoglou S, Khanov A, Kharchilava A, Klima B, Kohli JM, Kostritskiy AV, Kotcher J, Kothari B, Kozelov AV, Kozlovsky EA, Krane J, Krishnaswamy MR, Krivkova P, Krzywdzinski S, Kubantsev M, Kuleshov S, Kulik Y, Kunori S, Kupco A, Kuznetsov VE, Landsberg G, Lee WM, Leflat A, Lehner F, Leonidopoulos C, Li J, Li QZ, Lima JGR, Lincoln D, Linn SL, Linnemann J, Lipton R, Lucotte A, Lueking L, Lundstedt C, Luo C, Maciel AKA, Madaras RJ, Malyshev VL, Manankov V, Mao HS, Marshall T, Martin MI, Mattingly SEK, Mayorov AA, McCarthy R, McMahon T, Melanson HL, Melnitchouk A, Merkin A, Merritt KW, Miao C, Miettinen H, Mihalcea D, Mokhov N, Mondal NK, Montgomery HE, Moore RW, Mutaf YD, Nagy E, Narain M, Narasimham VS, Naumann NA, Neal HA, Negret JP, Nelson S, Nomerotski A, Nunnemann T, O'Neil D, Oguri V, Oshima N, Padley P, Papageorgiou K, Parashar N, Partridge R, Parua N, Patwa A, Peters O, Pétroff P, Piegaia R, Pope BG, Prosper HB, Protopopescu S, Przybycien MB, Qian J, Rajagopalan S, Rapidis PA, Reay NW, Reucroft S, Ridel M, Rijssenbeek M, Rizatdinova F, Rockwell T, Royon C, Rubinov P, Ruchti R, Sabirov BM, Sajot G, Santoro A, Sawyer L, Schamberger RD, Schellman H, Schwartzman A, Shabalina E, Shivpuri RK, Shpakov D, Shupe M, Sidwell RA, Simak V, Sirotenko V, Slattery P, Smith RP, Snow GR, Snow J, Snyder S, Solomon J, Song Y, Sorín V, Sosebee M, Sotnikova N, Soustruznik K, Souza M, Stanton NR, Steinbrück G, Stoker D, Stolin V, Stone A, Stoyanova DA, Strang MA, Strauss M, Strovink M, Stutte L, Sznajder A, Talby M, Taylor W, Tentindo-Repond S, Trippe TG, Turcot AS, Tuts PM, Van Kooten R, Vaniev V, Varelas N, Villeneuve-Seguier F, Volkov AA, Vorobiev AP, Wahl HD, Wang ZM, Warchol J, Watts G, Wayne M, Weerts H, White A, Whiteson D, Wijngaarden DA, Willis S, Wimpenny SJ, Womersley J, Wood DR, Xu Q, Yamada R, Yasuda T, Yatsunenko YA, Yip K, Yu J, Zanabria M, Zhang X, Zhou B, Zhou Z, Zielinski M, Zieminska D, Zieminski A, Zutshi V, Zverev EG, Zylberstejn A. A precision measurement of the mass of the top quark. Nature 2004; 429:638-42. [PMID: 15190311 DOI: 10.1038/nature02589] [Citation(s) in RCA: 203] [Impact Index Per Article: 10.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2004] [Accepted: 04/21/2004] [Indexed: 11/09/2022]
Abstract
The standard model of particle physics contains parameters--such as particle masses--whose origins are still unknown and which cannot be predicted, but whose values are constrained through their interactions. In particular, the masses of the top quark (M(t)) and W boson (M(W)) constrain the mass of the long-hypothesized, but thus far not observed, Higgs boson. A precise measurement of M(t) can therefore indicate where to look for the Higgs, and indeed whether the hypothesis of a standard model Higgs is consistent with experimental data. As top quarks are produced in pairs and decay in only about 10(-24) s into various final states, reconstructing their masses from their decay products is very challenging. Here we report a technique that extracts more information from each top-quark event and yields a greatly improved precision (of +/- 5.3 GeV/c2) when compared to previous measurements. When our new result is combined with our published measurement in a complementary decay mode and with the only other measurements available, the new world average for M(t) becomes 178.0 +/- 4.3 GeV/c2. As a result, the most likely Higgs mass increases from the experimentally excluded value of 96 to 117 GeV/c2, which is beyond current experimental sensitivity. The upper limit on the Higgs mass at the 95% confidence level is raised from 219 to 251 GeV/c2.
Collapse
Affiliation(s)
- V M Abazov
- Joint Institute for Nuclear Research, P O Box 79, 141980 Dubna, Russia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Abazov VM, Abbott B, Abdesselam A, Abolins M, Abramov V, Acharya BS, Adams DL, Adams M, Ahmed SN, Alexeev GD, Alton A, Alves GA, Anderson EW, Arnoud Y, Avila C, Babintsev VV, Babukhadia L, Bacon TC, Baden A, Baffioni S, Baldin B, Balm PW, Banerjee S, Barberis E, Baringer P, Barreto J, Bartlett JF, Bassler U, Bauer D, Bean A, Beaudette F, Begel M, Belyaev A, Beri SB, Bernardi G, Bertram I, Besson A, Beuselinck R, Bezzubov VA, Bhat PC, Bhatnagar V, Bhattacharjee M, Blazey G, Blekman F, Blessing S, Boehnlein A, Bojko NI, Bolton TA, Borcherding F, Bos K, Bose T, Brandt A, Briskin G, Brock R, Brooijmans G, Bross A, Buchholz D, Buehler M, Buescher V, Burtovoi VS, Butler JM, Canelli F, Carvalho W, Casey D, Castilla-Valdez H, Chakraborty D, Chan KM, Chekulaev SV, Cho DK, Choi S, Chopra S, Claes D, Clark AR, Connolly B, Cooper WE, Coppage D, Crépé-Renaudin S, Cummings MAC, Cutts D, da Motta H, Davis GA, De K, de Jong SJ, Demarteau M, Demina R, Demine P, Denisov D, Denisov SP, Desai S, Diehl HT, Diesburg M, Doulas S, Dudko LV, Duensing S, Duflot L, Dugad SR, Duperrin A, Dyshkant A, Edmunds D, Ellison J, Eltzroth JT, Elvira VD, Engelmann R, Eno S, Eppley G, Ermolov P, Eroshin OV, Estrada J, Evans H, Evdokimov VN, Fein D, Ferbel T, Filthaut F, Fisk HE, Fleuret F, Fortner M, Fox H, Fu S, Fuess S, Gallas E, Galyaev AN, Gao M, Gavrilov V, Genik RJ, Genser K, Gerber CE, Gershtein Y, Ginther G, Gómez B, Goncharov PI, Gordon H, Gounder K, Goussiou A, Graf N, Grannis PD, Green JA, Greenlee H, Greenwood ZD, Grinstein S, Groer L, Grünendahl S, Gurzhiev SN, Gutierrez G, Gutierrez P, Hadley NJ, Haggerty H, Hagopian S, Hagopian V, Hall RE, Han C, Hansen S, Hauptman JM, Hebert C, Hedin D, Heinmiller JM, Heinson AP, Heintz U, Hildreth MD, Hirosky R, Hobbs JD, Hoeneisen B, Huang J, Huang Y, Iashvili I, Illingworth R, Ito AS, Jaffré M, Jain S, Jesik R, Johns K, Johnson M, Jonckheere A, Jöstlein H, Juste A, Kahl W, Kahn S, Kajfasz E, Kalinin AM, Karmanov D, Karmgard D, Kehoe R, Khanov A, Kharchilava A, Klima B, Kohli JM, Kostritskiy AV, Kotcher J, Kothhari B, Kozelov AV, Kozlovsky EA, Krane J, Krishnaswamy MR, Krivkova P, Krzywdzinski S, Kubantsev M, Kuleshov S, Kulik Y, Kunori S, Kupco A, Kuznetsov VE, Landsberg G, Lee WM, Leflat A, Lehner F, Leonidopoulos C, Li J, Li QZ, Lima JGR, Lincoln D, Linn SL, Linnemann J, Lipton R, Lucotte A, Lueking L, Lundstedt C, Luo C, Maciel AKA, Madaras RJ, Malyshev VL, Manankov V, Mao HS, Marshall T, Martin MI, Mayorov AA, McCarthy R, McMahon T, Melanson HL, Merkin M, Merritt KW, Miao C, Miettinen H, Mihalcea D, Mokhov N, Mondal NK, Montgomery HE, Moore RW, Mutaf YD, Nagy E, Nang F, Narain M, Narasimham VS, Naumann NA, Neal HA, Negret JP, Nomerotski A, Nunnemann T, O'Neil D, Oguri V, Olivier B, Oshima N, Padley P, Papageorgiou K, Parashar N, Partridge R, Parua N, Patwa A, Peters O, Pétroff P, Piegaia R, Pope BG, Prosper HB, Protopopescu S, Przybycien MB, Qian J, Quadt A, Raja R, Rajagopalan S, Rapidis PA, Reay NW, Reucroft S, Ridel M, Rijssenbeek M, Rizatdinova F, Rockwell T, Royon C, Rubinov P, Ruchti R, Sabirov BM, Sajot G, Santoro A, Sawyer L, Schamberger RD, Schellman H, Schwartzman A, Shabalina E, Shivpuri RK, Shpakov D, Shupe M, Sidwell RA, Simak V, Sirotenko V, Slattery P, Smith RP, Snow GR, Snow J, Snyder S, Solomon J, Song Y, Sorín V, Sosebee M, Sotnikova N, Soustruznik K, Souza M, Stanton NR, Steinbrück G, Stoker D, Stolin V, Stone A, Stoyanova DA, Strang MA, Strauss M, Strovink M, Stutte L, Sznajder A, Talby M, Taylor W, Tentindo-Repond S, Tripathi SM, Trippe TG, Turcot AS, Tuts PM, Van Kooten R, Vaniev V, Varelas N, Villeneuve-Seguier F, Volkov AA, Vorobiev AP, Wahl HD, Wang ZM, Warchol J, Watts G, Wayne M, Weerts H, White A, Whiteson D, Wijngaarden DA, Willis S, Wimpenny SJ, Womersley J, Wood DR, Xu Q, Yamada R, Yamin P, Yasuda T, Yatsunenko YA, Yip K, Yu J, Zanabria M, Zhang X, Zheng H, Zhou B, Zhou Z, Zielinski M, Zieminska D, Zieminski A, Zutshi V, Zverev EG, Zylberstejn A. Search for narrow tt resonances in pp collisions at square root of (s)=1.8 TeV. Phys Rev Lett 2004; 92:221801. [PMID: 15245211 DOI: 10.1103/physrevlett.92.221801] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/29/2003] [Indexed: 05/24/2023]
Abstract
A search for narrow resonances that decay into tt pairs has been performed using 130 pb(-1) of data in the lepton + jets channel collected by the Dphi detector in pp collisions at square root of (s)=1.8 TeV. There is no significant deviation observed from the standard-model predictions at a top-quark mass of 175 GeV/c2. We therefore present upper limits at the 95% confidence level on the product of the production cross section and branching fraction to tt for narrow resonances as a function of the resonance mass MX. These limits are used to exclude the existence of a leptophobic top-color particle with mass MX<560 GeV/c2, using a theoretical cross section for a width GammaX=0.012MX.
Collapse
Affiliation(s)
- V M Abazov
- Joint Institute for Nuclear Research, Dubna, Russia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Affiliation(s)
- V Scott
- Department of Medicine, University of Birmingham, Queen Elizabeth Hospital, UK
| | | | | |
Collapse
|
48
|
Abstract
Synthetic glucocorticoids (GCs) potently inhibit the expression of pro-inflammatory genes and are widely used in the treatment of inflammatory diseases. However, some patients are resistant to the therapeutic effects of GCs, and many suffer deleterious side effects from these drugs. Furthermore, the precise mechanisms by which GCs inhibit pro-inflammatory gene expression remain unclear. A number of recent papers report that GCs induce the sustained expression of MAP kinase (MAPK) phosphatase 1 (MKP-1), a negative regulator of MAPK signal transduction pathways. The potential relevance of MKP-1 to some of the biological effects of GCs is discussed.
Collapse
Affiliation(s)
- A R Clark
- Kennedy Institute of Rheumatology Division, Faculty of Medicine, Imperial College London, 1 Aspenlea Road, Hammersmith, London W6 8LH, United Kingdom.
| |
Collapse
|
49
|
Abazov VM, Abbott B, Abdesselam A, Abolins M, Abramov V, Acharya BS, Adams DL, Adams M, Ahmed SN, Alexeev GD, Alton A, Alves GA, Anderson EW, Arnoud Y, Avila C, Babintsev VV, Babukhadia L, Bacon TC, Baden A, Baffioni S, Baldin B, Balm PW, Banerjee S, Barberis E, Baringer P, Barreto J, Bartlett JF, Bassler U, Bauer D, Bean A, Beaudette F, Begel M, Belyaev A, Beri SB, Bernardi G, Bertram I, Besson A, Beuselinck R, Bezzubov VA, Bhat PC, Bhatnagar V, Bhattacharjee M, Blazey G, Blekman F, Blessing S, Boehnlein A, Bojko NI, Bolton TA, Borcherding F, Bos K, Bose T, Brandt A, Breedon R, Briskin G, Brock R, Brooijmans G, Bross A, Buchholz D, Buehler M, Buescher V, Burtovoi VS, Butler JM, Canelli F, Carvalho W, Casey D, Casilum Z, Castilla-Valdez H, Chakraborty D, Chan KM, Chekulaev SV, Cho DK, Choi S, Chopra S, Christenson JH, Claes D, Clark AR, Coney L, Connolly B, Cooper WE, Coppage D, Crépé-Renaudin S, Cummings MAC, Cutts D, da Motta H, Davis GA, De K, de Jong SJ, Demarteau M, Demina R, Demine P, Denisov D, Denisov SP, Desai S, Diehl HT, Diesburg M, Doulas S, Dudko LV, Duensing S, Duflot L, Dugad SR, Duperrin A, Dyshkant A, Edmunds D, Ellison J, Eltzroth JT, Elvira VD, Engelmann R, Eno S, Eppley G, Ermolov P, Eroshin OV, Estrada J, Evans H, Evdokimov VN, Fein D, Ferbel T, Filthaut F, Fisk HE, Fisyak Y, Fleuret F, Fortner M, Fox H, Fu S, Fuess S, Gallas E, Galyaev AN, Gao M, Gavrilov V, Genik RJ, Genser K, Gerber CE, Gershtein Y, Ginther G, Gómez B, Goncharov PI, Gordon H, Goss LT, Gounder K, Goussiou A, Graf N, Grannis PD, Green JA, Greenlee H, Greenwood ZD, Grinstein S, Groer L, Grünendahl S, Gurzhiev SN, Gutierrez G, Gutierrez P, Hadley NJ, Haggerty H, Hagopian S, Hagopian V, Hall RE, Han C, Hansen S, Hauptman JM, Hebert C, Hedin D, Heinmiller JM, Heinson AP, Heintz U, Hildreth MD, Hirosky R, Hobbs JD, Hoeneisen B, Huang J, Huang Y, Iashvili I, Illingworth R, Ito AS, Jaffré M, Jain S, Jesik R, Johns K, Johnson M, Jonckheere A, Jöstlein H, Juste A, Kahl W, Kahn S, Kajfasz E, Kalinin AM, Karmanov D, Karmgard D, Kehoe R, Khanov A, Kharchilava A, Klima B, Knuteson B, Ko W, Kohli JM, Kostritskiy AV, Kotcher J, Kothari B, Kozelov AV, Kozlovsky EA, Krane J, Krishnaswamy MR, Krivkova P, Krzywdzinski S, Kubantsev M, Kuleshov S, Kulik Y, Kunori S, Kupco A, Kuznetsov VE, Landsberg G, Lee WM, Leflat A, Leggett C, Lehner F, Leonidopoulos C, Li J, Li QZ, Lima JGR, Lincoln D, Linn SL, Linnemann J, Lipton R, Lucotte A, Lueking L, Lundstedt C, Luo C, Maciel AKA, Madaras RJ, Malyshev VL, Manankov V, Mao HS, Marshall T, Martin MI, Mayorov AA, McCarthy R, McMahon T, Melanson HL, Merkin M, Merritt KW, Miao C, Miettinen H, Mihalcea D, Mishra CS, Mokhov N, Mondal NK, Montgomery HE, Moore RW, Mutaf YD, Nagy E, Nang F, Narain M, Narasimham VS, Naumann NA, Neal HA, Negret JP, Nomerotski A, Nunnemann T, O'Neil D, Oguri V, Olivier B, Oshima N, Padley P, Papageorgiou K, Parashar N, Partridge R, Parua N, Patwa A, Peters O, Pétroff P, Piegaia R, Pope BG, Popkov E, Prosper HB, Protopopescu S, Przybycien MB, Qian J, Raja R, Rajagopalan S, Rapidis PA, Reay NW, Reucroft S, Ridel M, Rijssenbeek M, Rizatdinova F, Rockwell T, Royon C, Rubinov P, Ruchti R, Rutherfoord J, Sabirov BM, Sajot G, Santoro A, Sawyer L, Schamberger RD, Schellman H, Schwartzman A, Shabalina E, Shivpuri RK, Shpakov D, Shupe M, Sidwell RA, Simak V, Sirotenko V, Slattery P, Smith RP, Snow GR, Snow J, Snyder S, Solomon J, Song Y, Sorín V, Sosebee M, Sotnikova N, Soustruznik K, Souza M, Stanton NR, Steinbrück G, Stoker D, Stolin V, Stone A, Stoyanova DA, Strang MA, Strauss M, Strovink M, Stutte L, Sznajder A, Talby M, Taylor W, Tentindo-Repond S, Tripathi SM, Trippe TG, Turcot AS, Tuts PM, Van Kooten R, Vaniev V, Varelas N, Vertogradov LS, Villeneuve-Seguier F, Volkov AA, Vorobiev AP, Wahl HD, Wang ZM, Warchol J, Watts G, Wayne M, Weerts H, White A, White JT, Whiteson D, Wijngaarden DA, Willis S, Wimpenny SJ, Womersley J, Wood DR, Xu Q, Yamada R, Yamin P, Yasuda T, Yatsunenko YA, Yip K, Youssef S, Yu J, Zanabria M, Zhang X, Zheng H, Zhou B, Zhou Z, Zielinski M, Zieminska D, Zieminski A, Zutshi V, Zverev EG, Zylberstejn A. Search for large extra dimensions in the monojet+E(T) channel with the DØ detector. Phys Rev Lett 2003; 90:251802. [PMID: 12857124 DOI: 10.1103/physrevlett.90.251802] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/11/2003] [Indexed: 05/24/2023]
Abstract
We present a search for large extra dimensions (ED) in pp collisions at a center-of-mass energy of 1.8 TeV using data collected by the DØ detector at the Fermilab Tevatron in 1994-1996. Data corresponding to 78.8+/-3.9 pb(-1) are examined for events with large missing transverse energy, one high-p(T) jet, and no isolated muons. There is no excess observed beyond expectation from the standard model, and we place lower limits on the fundamental Planck scale of 1.0 and 0.6 TeV for 2 and 7 ED, respectively.
Collapse
Affiliation(s)
- V M Abazov
- Joint Institute for Nuclear Research, Dubna, Russia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Abazov VM, Abbott B, Abdesselam A, Abolins M, Abramov V, Acharya BS, Adams DL, Adams M, Ahmed SN, Alexeev GD, Alton A, Alves GA, Anderson EW, Arnoud Y, Avila C, Babintsev VV, Babukhadia L, Bacon TC, Baden A, Baldin B, Balm PW, Banerjee S, Barberis E, Baringer P, Barreto J, Bartlett JF, Bassler U, Bauer D, Bean A, Beaudette F, Begel M, Belyaev A, Beri SB, Bernardi G, Bertram I, Besson A, Beuselinck R, Bezzubov VA, Bhat PC, Bhatnagar V, Bhattacharjee M, Blazey G, Blekman F, Blessing S, Boehnlein A, Bojko NI, Bolton TA, Borcherding F, Bos K, Bose T, Brandt A, Breedon R, Briskin G, Brock R, Brooijmans G, Bross A, Buchholz D, Buehler M, Buescher V, Burtovoi VS, Butler JM, Canelli F, Carvalho W, Casey D, Casilum Z, Castilla-Valdez H, Chakraborty D, Chan KM, Chekulaev SV, Cho DK, Choi S, Chopra S, Christenson JH, Claes D, Clark AR, Coney L, Connolly B, Cooper WE, Coppage D, Crépé-Renaudin S, Cummings MAC, Cutts D, Davis GA, De K, De Jong SJ, Demarteau M, Demina R, Demine P, Denisov D, Denisov SP, Desai S, Diehl HT, Diesburg M, Doulas S, Ducros Y, Dudko LV, Duensing S, Duflot L, Dugad SR, Duperrin A, Dyshkant A, Edmunds D, Ellison J, Eltzroth JT, Elvira VD, Engelmann R, Eno S, Eppley G, Ermolov P, Eroshin OV, Estrada J, Evans H, Evdokimov VN, Fein D, Ferbel T, Filthaut F, Fisk HE, Fisyak Y, Flattum E, Fleuret F, Fortner M, Fox H, Fu S, Fuess S, Gallas E, Galyaev AN, Gao M, Gavrilov V, Genik RJ, Genser K, Gerber CE, Gershtein Y, Gilmartin R, Ginther G, Gómez B, Goncharov PI, Gordon H, Goss LT, Gounder K, Goussiou A, Graf N, Grannis PD, Green JA, Greenlee H, Greenwood ZD, Grinstein S, Groer L, Grünendahl S, Gupta A, Gurzhiev SN, Gutierrez G, Gutierrez P, Hadley NJ, Haggerty H, Hagopian S, Hagopian V, Hall RE, Hansen S, Hauptman JM, Hays C, Hebert C, Hedin D, Heinmiller JM, Heinson AP, Heintz U, Hildreth MD, Hirosky R, Hobbs JD, Hoeneisen B, Huang Y, Iashvili I, Illingworth R, Ito AS, Jaffré M, Jain S, Jesik R, Johns K, Johnson M, Jonckheere A, Jöstlein H, Juste A, Kahl W, Kahn S, Kajfasz E, Kalinin AM, Karmanov D, Karmgard D, Kehoe R, Khanov A, Kharchilava A, Kim SK, Klima B, Knuteson B, Ko W, Kohli JM, Kostritskiy AV, Kotcher J, Kothari B, Kozelov AV, Kozlovsky EA, Krane J, Krishnaswamy MR, Krivkova P, Krzywdzinski S, Kubantsev M, Kuleshov S, Kulik Y, Kunori S, Kupco A, Kuznetsov VE, Landsberg G, Lee WM, Leflat A, Leggett C, Lehner F, Leonidopoulos C, Li J, Li QZ, Lima JGR, Lincoln D, Linn SL, Linnemann J, Lipton R, Lucotte A, Lueking L, Lundstedt C, Luo C, Maciel AKA, Madaras RJ, Malyshev VL, Manankov V, Mao HS, Marshall T, Martin MI, Mayorov AA, McCarthy R, McMahon T, Melanson HL, Merkin M, Merritt KW, Miao C, Miettinen H, Mihalcea D, Mishra CS, Mokhov N, Mondal NK, Montgomery HE, Moore RW, Mostafa M, Da Motta H, Mutaf YD, Nagy E, Nang F, Narain M, Narasimham VS, Naumann NA, Neal HA, Negret JP, Nomerotski A, Nunnemann T, O'Neil D, Oguri V, Olivier B, Oshima N, Padley P, Papageorgiou K, Parashar N, Partridge R, Parua N, Patwa A, Peters O, Pétroff P, Piegaia R, Pope BG, Popkov E, Prosper HB, Protopopescu S, Przybycien MB, Qian J, Raja R, Rajagopalan S, Rapidis PA, Reay NW, Reucroft S, Ridel M, Rijssenbeek M, Rizatdinova F, Rockwell T, Roco M, Royon C, Rubinov P, Ruchti R, Rutherfoord J, Sabirov BM, Sajot G, Santoro A, Sawyer L, Schamberger RD, Schellman H, Schwartzman A, Shabalina E, Shivpuri RK, Shpakov D, Shupe M, Sidwell RA, Simak V, Singh H, Sirotenko V, Slattery P, Smith RP, Snihur R, Snow GR, Snow J, Snyder S, Solomon J, Song Y, Sorín V, Sosebee M, Sotnikova N, Soustruznik K, Souza M, Stanton NR, Steinbrück G, Stephens RW, Stoker D, Stolin V, Stone A, Stoyanova DA, Strang MA, Strauss M, Strovink M, Stutte L, Sznajder A, Talby M, Taylor W, Tentindo-Repond S, Tripathi SM, Trippe TG, Turcot AS, Tuts PM, Vaniev V, Kooten RV, Varelas N, Vertogradov LS, Villeneuve-Seguier F, Volkov AA, Vorobiev AP, Wahl HD, Wang H, Wang ZM, Warchol J, Watts G, Wayne M, Weerts H, White A, White JT, Whiteson D, Wijngaarden DA, Willis S, Wimpenny SJ, Womersley J, Wood DR, Xu Q, Yamada R, Yamin P, Yasuda T, Yatsunenko YA, Yip K, Youssef S, Yu J, Zanabria M, Zhang X, Zheng H, Zhou B, Zhou Z, Zielinski M, Zieminska D, Zieminski A, Zutshi V, Zverev EG, Zylberstejn A. Search for the production of single sleptons through R-parity violation in pp; collisions at square root (s) =1.8 TeV. Phys Rev Lett 2002; 89:261801. [PMID: 12484810 DOI: 10.1103/physrevlett.89.261801] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/31/2002] [Indexed: 05/24/2023]
Abstract
We report the first search for supersymmetric particles via s-channel production and decay of smuons or muon sneutrinos at hadronic colliders. The data for the two-muon and two-jets final states were collected by the D0 experiment and correspond to an integrated luminosity of 94+/-5 pb(-1). Assuming that R parity is violated via the single coupling lambda'211, the number of candidate events is in agreement with expectation from the standard model. Exclusion contours are given in the (m(0),m(1/2)) and (m(x),m(v)) planes for lambda(')(211)=0.09, 0.08, and 0.07.
Collapse
Affiliation(s)
- V M Abazov
- Joint Institute for Nuclear Research, Dubna, Russia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|